Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Inflammatory Bowel Diseases

  Free Subscription


Articles published in Inflamm Bowel Dis

Retrieve available abstracts of 548 articles:
HTML format
Text format



Single Articles


    July 2017
  1. JANMOHAMED N, Steinhart AH
    Measuring Severity of Anxiety and Depression in Patients with Inflammatory Bowel Disease: Low Concordance Between Patients and Male Gastroenterologists.
    Inflamm Bowel Dis. 2017;23:1168-1173.
    PubMed     Text format     Abstract available


  2. KHALILI H, de Silva PS, Ananthakrishnan AN, Lochhead P, et al
    Dietary Iron and Heme Iron Consumption, Genetic Susceptibility, and Risk of Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:1088-1095.
    PubMed     Text format     Abstract available


    June 2017
  3. MA C, Lumb R, Walker EV, Foshaug RR, et al
    Noninvasive Fecal Immunochemical Testing and Fecal Calprotectin Predict Mucosal Healing in Inflammatory Bowel Disease: A Prospective Cohort Study.
    Inflamm Bowel Dis. 2017 Jun 20. doi: 10.1097/MIB.0000000000001173.
    PubMed     Text format     Abstract available


  4. CARLSEN K, Houen G, Jakobsen C, Kallemose T, et al
    Individualized Infliximab Treatment Guided by Patient-managed eHealth in Children and Adolescents with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jun 14. doi: 10.1097/MIB.0000000000001170.
    PubMed     Text format     Abstract available


  5. MEIJER B, Seinen ML, van Egmond R, Bouma G, et al
    Optimizing Thiopurine Therapy in Inflammatory Bowel Disease Among 2 Real-life Intercept Cohorts: Effect of Allopurinol Comedication?
    Inflamm Bowel Dis. 2017 Jun 14. doi: 10.1097/MIB.0000000000001168.
    PubMed     Text format     Abstract available


  6. EPPINGA H, Poortinga S, Thio HB, Nijsten TEC, et al
    Prevalence and Phenotype of Concurrent Psoriasis and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jun 14. doi: 10.1097/MIB.0000000000001169.
    PubMed     Text format     Abstract available


  7. PEDERSEN M, Cromwell J, Nau P
    Sarcopenia is a Predictor of Surgical Morbidity in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jun 9. doi: 10.1097/MIB.0000000000001166.
    PubMed     Text format     Abstract available


  8. PEKOW J, Hutchison AL, Meckel K, Harrington K, et al
    miR-4728-3p Functions as a Tumor Suppressor in Ulcerative Colitis-associated Colorectal Neoplasia Through Regulation of Focal Adhesion Signaling.
    Inflamm Bowel Dis. 2017 Jun 7. doi: 10.1097/MIB.0000000000001104.
    PubMed     Text format     Abstract available


  9. KOPYLOV U, Papamichael K, Katsanos K, Waterman M, et al
    Impact of Infliximab and Cyclosporine on the Risk of Colectomy in Hospitalized Patients with Ulcerative Colitis Complicated by Cytomegalovirus-A Multicenter Retrospective Study.
    Inflamm Bowel Dis. 2017 Jun 5. doi: 10.1097/MIB.0000000000001160.
    PubMed     Text format     Abstract available


  10. PATEL A, Panchal H, Dubinsky MC
    Fecal Calprotectin Levels Predict Histological Healing in Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Jun 5. doi: 10.1097/MIB.0000000000001157.
    PubMed     Text format     Abstract available


  11. AXELRAD JE, Joelson A, Nobel YR, Lawlor G, et al
    Enteric Infection in Relapse of Inflammatory Bowel Disease: The Utility of Stool Microbial PCR Testing.
    Inflamm Bowel Dis. 2017;23:1034-1039.
    PubMed     Text format     Abstract available


  12. GLASSNER K, Malaty HM, Abraham BP
    Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease Among Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:998-1003.
    PubMed     Text format     Abstract available


  13. HEIDA A, Park KT, van Rheenen PF
    Clinical Utility of Fecal Calprotectin Monitoring in Asymptomatic Patients with Inflammatory Bowel Disease: A Systematic Review and Practical Guide.
    Inflamm Bowel Dis. 2017;23:894-902.
    PubMed     Text format     Abstract available


  14. NGUYEN GC, Boland K, Afif W, Bressler B, et al
    Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:858-865.
    PubMed     Text format     Abstract available


  15. YADAV A, Foromera J, Feuerstein I, Falchuk KR, et al
    Variations in Health Insurance Policies Regarding Biologic Therapy Use in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:853-857.
    PubMed     Text format     Abstract available


  16. BERRY AC, Dholaria K, Czul-Gurdian F, Forster E, et al
    Relationship Between Patient Knowledge and Medication Adherence in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E39-E40.
    PubMed     Text format    


  17. HOPKINS CWP, Butt HS, Moulton CD
    Beyond Efficacy: The Acceptability of Antidepressant Treatment to Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E38.
    PubMed     Text format    


    May 2017
  18. BUISSON A, Gonzalez F, Poullenot F, Nancey S, et al
    Comparative Acceptability and Perceived Clinical Utility of Monitoring Tools: A Nationwide Survey of Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001140.
    PubMed     Text format     Abstract available


  19. LOPEZ RN, Evans HM, Appleton L, Bishop J, et al
    Point Prevalence of Pediatric Inflammatory Bowel Disease in New Zealand in 2015: Initial Results from the PINZ Study.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001138.
    PubMed     Text format     Abstract available


  20. FEAGINS LA, Waljee A, Hou JK, Gu P, et al
    Incidence of and Predictors for Early Discontinuation of Biological Therapies in Veteran Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001145.
    PubMed     Text format     Abstract available


  21. CHAO K, Wang X, Cao Q, Qian J, et al
    Combined Detection of NUDT15 Variants Could Highly Predict Thiopurine-induced Leukopenia in Chinese Patients with Inflammatory Bowel Disease: A Multicenter Analysis.
    Inflamm Bowel Dis. 2017 May 24. doi: 10.1097/MIB.0000000000001148.
    PubMed     Text format     Abstract available


  22. BORREN NZ, Conway G, Tan W, Andrews E, et al
    Distance to Specialist Care and Disease Outcomes in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 16. doi: 10.1097/MIB.0000000000001133.
    PubMed     Text format     Abstract available


  23. VALER P, Algaba A, Santos D, Fuentes ME, et al
    Evaluation of the Quality of Semen and Sexual Function in Men with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 16. doi: 10.1097/MIB.0000000000001081.
    PubMed     Text format     Abstract available


  24. FATTAHI MR, Malek-Hosseini SA, Sivandzadeh GR, Safarpour AR, et al
    Clinical Course of Ulcerative Colitis After Liver Transplantation in Patients with Concomitant Primary Sclerosing Cholangitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 May 16. doi: 10.1097/MIB.0000000000001105.
    PubMed     Text format     Abstract available


  25. NGUYEN GC, Boland K, Afif W, Bressler B, et al
    Modified Delphi Process for the Development of Choosing Wisely for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 15. doi: 10.1097/MIB.0000000000001152.
    PubMed     Text format     Abstract available


  26. YADAV A, Foromera J, Feuerstein I, Falchuk KR, et al
    Variations in Health Insurance Policies Regarding Biologic Therapy Use in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 15. doi: 10.1097/MIB.0000000000001153.
    PubMed     Text format     Abstract available


  27. JULSGAARD M, Hvas CL, Gearry RB, Vestergaard T, et al
    Fecal Calprotectin Is Not Affected by Pregnancy: Clinical Implications for the Management of Pregnant Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001136.
    PubMed     Text format     Abstract available


  28. RESTALL GJ, Simms AM, Walker JR, Haviva C, et al
    Coping with Inflammatory Bowel Disease: Engaging with Information to Inform Health-Related Decision Making in Daily Life.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001141.
    PubMed     Text format     Abstract available


  29. KELLY OB, Donnell SO, Stempak JM, Steinhart AH, et al
    Therapeutic Drug Monitoring to Guide Infliximab Dose Adjustment is Associated with Better Endoscopic Outcomes than Clinical Decision Making Alone in Active Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001126.
    PubMed     Text format     Abstract available


  30. JEGANATHAN J, Lee CH, Rahme A, Tiao DK, et al
    Pediatric-to-adult Transition and Medication Adherence in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001114.
    PubMed     Text format     Abstract available


  31. GUNALTAY S, Repsilber D, Helenius G, Nyhlin N, et al
    Oligoclonal T-cell Receptor Repertoire in Colonic Biopsies of Patients with Microscopic Colitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 May 11. doi: 10.1097/MIB.0000000000001127.
    PubMed     Text format     Abstract available


  32. YANG H, Zhou W, Lv H, Wu D, et al
    The Association Between CMV Viremia or Endoscopic Features and Histopathological Characteristics of CMV Colitis in Patients with Underlying Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:814-821.
    PubMed     Text format     Abstract available


  33. THORLACIUS-USSING G, Schnack Nielsen B, Andersen V, Holmstrom K, et al
    Expression and Localization of miR-21 and miR-126 in Mucosal Tissue from Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:739-752.
    PubMed     Text format     Abstract available


  34. BURKE KE, Haviland MJ, Hacker MR, Shainker SA, et al
    Indications for Mode of Delivery in Pregnant Women with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:721-726.
    PubMed     Text format     Abstract available


  35. FOULON A, Dupas JL, Sabbagh C, Chevreau J, et al
    Defining the Most Appropriate Delivery Mode in Women with Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2017;23:712-720.
    PubMed     Text format     Abstract available


  36. NGUYEN GC, Murthy SK, Bressler B, Lam MCW, et al
    Quality of Care and Outcomes Among Hospitalized Inflammatory Bowel Disease Patients: A Multicenter Retrospective Study.
    Inflamm Bowel Dis. 2017;23:695-701.
    PubMed     Text format     Abstract available


    April 2017
  37. VAVRICKA SR, Gubler M, Gantenbein C, Spoerri M, et al
    Anti-TNF Treatment for Extraintestinal Manifestations of Inflammatory Bowel Disease in the Swiss IBD Cohort Study.
    Inflamm Bowel Dis. 2017 Apr 27. doi: 10.1097/MIB.0000000000001109.
    PubMed     Text format     Abstract available


  38. MAGNUSSON MK, Strid H, Isaksson S, Simren M, et al
    The Mucosal Antibacterial Response Profile and Fecal Microbiota Composition Are Linked to the Disease Course in Patients with Newly Diagnosed Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Apr 25. doi: 10.1097/MIB.0000000000001130.
    PubMed     Text format     Abstract available


  39. JACOB V, Crawford C, Cohen-Mekelburg S, Viladomiu M, et al
    Single Delivery of High-Diversity Fecal Microbiota Preparation by Colonoscopy Is Safe and Effective in Increasing Microbial Diversity in Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Apr 25. doi: 10.1097/MIB.0000000000001132.
    PubMed     Text format     Abstract available


  40. BUHL S, Steenholdt C, Rasmussen M, Borghede MK, et al
    Outcomes After Primary Infliximab Treatment Failure in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Apr 25. doi: 10.1097/MIB.0000000000001117.
    PubMed     Text format     Abstract available


  41. BARNES EL, Kochar B, Long MD, Kappelman MD, et al
    Modifiable Risk Factors for Hospital Readmission Among Patients with Inflammatory Bowel Disease in a Nationwide Database.
    Inflamm Bowel Dis. 2017 Apr 19. doi: 10.1097/MIB.0000000000001121.
    PubMed     Text format     Abstract available


  42. LIGHTNER AL, Tse CS, Quinn K, Bergquist JR, et al
    Preoperative Clostridium difficile Infection Does Not Affect Pouch Outcomes in Patients with Ulcerative Colitis Who Undergo Ileal Pouch-anal Anastomosis.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001122.
    PubMed     Text format     Abstract available


  43. MARTINEZ B, Dailey F, Almario CV, Keller MS, et al
    Patient Understanding of the Risks and Benefits of Biologic Therapies in Inflammatory Bowel Disease: Insights from a Large-scale Analysis of Social Media Platforms.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001110.
    PubMed     Text format     Abstract available


  44. ADAMS DW, Gurwara S, Silver HJ, Horst SN, et al
    Sarcopenia Is Common in Overweight Patients with Inflammatory Bowel Disease and May Predict Need for Surgery.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001128.
    PubMed     Text format     Abstract available


  45. KOCHAR B, Long MD, Galanko J, Raffals LE, et al
    Inflammatory Bowel Disease is Similar in Patients with Older Onset and Younger Onset.
    Inflamm Bowel Dis. 2017 Apr 13. doi: 10.1097/MIB.0000000000001115.
    PubMed     Text format     Abstract available


  46. VARNI JW, Shulman RJ, Self MM, Saeed SA, et al
    Patient Health Communication Mediating Effects Between Gastrointestinal Symptoms and Gastrointestinal Worry in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Apr 6. doi: 10.1097/MIB.0000000000001077.
    PubMed     Text format     Abstract available


  47. BANASZKIEWICZ A, Gawronska A, Klincewicz B, Kofla-Dlubacz A, et al
    Immunogenicity of Pertussis Booster Vaccination in Children and Adolescents with Inflammatory Bowel Disease: A Controlled Study.
    Inflamm Bowel Dis. 2017 Apr 6. doi: 10.1097/MIB.0000000000001076.
    PubMed     Text format     Abstract available


  48. NAVANEETHAN U, Edminister T, Zhu X, Kommaraju K, et al
    Vedolizumab Is Safe and Effective in Elderly Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E17.
    PubMed     Text format    


  49. KHAN A, Chandler M, Borum ML
    Patients with Inflammatory Bowel Disease May Use Electronic Communication with Their Physicians More Frequently Than Those Without Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:E16.
    PubMed     Text format    


  50. STOCCO G, Martelossi S, Arrigo S, Barabino A, et al
    Multicentric Case-Control Study on Azathioprine Dose and Pharmacokinetics in Early-onset Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:628-634.
    PubMed     Text format     Abstract available


  51. TANDON P, James P, Cordeiro E, Mallick R, et al
    Diagnostic Accuracy of Blood-Based Tests and Histopathology for Cytomegalovirus Reactivation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis.
    Inflamm Bowel Dis. 2017;23:551-560.
    PubMed     Text format     Abstract available


  52. LAN N, Shen B
    Endoscopic Stricturotomy with Needle Knife in the Treatment of Strictures from Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:502-513.
    PubMed     Text format     Abstract available


  53. RUBIN DT, Dubinsky MC, Martino S, Hewett KA, et al
    Communication Between Physicians and Patients with Ulcerative Colitis: Reflections and Insights from a Qualitative Study of In-Office Patient-Physician Visits.
    Inflamm Bowel Dis. 2017;23:494-501.
    PubMed     Text format     Abstract available


    March 2017
  54. NARULA N, Borges L, Steinhart AH, Colombel JF, et al
    Trends in Narcotic and Corticosteroid Prescriptions in Patients with Inflammatory Bowel Disease in the United States Ambulatory Care Setting from 2003 to 2011.
    Inflamm Bowel Dis. 2017 Mar 31. doi: 10.1097/MIB.0000000000001084.
    PubMed     Text format     Abstract available


  55. SUZUKI Y, Iida M, Ito H, Nishino H, et al
    2.4 g Mesalamine (Asacol 400 mg tablet) Once Daily is as Effective as Three Times Daily in Maintenance of Remission in Ulcerative Colitis: A Randomized, Noninferiority, Multi-center Trial.
    Inflamm Bowel Dis. 2017 Mar 31. doi: 10.1097/MIB.0000000000001065.
    PubMed     Text format     Abstract available


  56. ANANTHAKRISHNAN AN, Donaldson T, Lasch K, Yajnik V, et al
    Management of Inflammatory Bowel Disease in the Elderly Patient: Challenges and Opportunities.
    Inflamm Bowel Dis. 2017 Mar 27. doi: 10.1097/MIB.0000000000001099.
    PubMed     Text format     Abstract available


  57. KAMMERLANDER H, Nielsen J, Kjeldsen J, Knudsen T, et al
    The Effect of Disease Activity on Birth Outcomes in a Nationwide Cohort of Women with Moderate to Severe Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Mar 24. doi: 10.1097/MIB.0000000000001102.
    PubMed     Text format     Abstract available


  58. HATA K, Ishii H, Anzai H, Ishihara S, et al
    Preoperative Extraintestinal Manifestations Associated with Chronic Pouchitis in Japanese Patients with Ulcerative Colitis After Ileal Pouch-anal Anastomosis: A Retrospective Study.
    Inflamm Bowel Dis. 2017 Mar 24. doi: 10.1097/MIB.0000000000001094.
    PubMed     Text format     Abstract available


  59. ZULLOW S, Fazelat A, Farraye FA
    Central Serous Chorioretinopathy in a Patient with Ulcerative Colitis with Pouchitis on Budesonide-EC.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001091.
    PubMed     Text format    


  60. EL-MATARY W
    Indicators of Quality of Care in Inflammatory Bowel Disease: Seeking the Right Path for Patients.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001069.
    PubMed     Text format    


  61. KHAN N, Patel D, Shah Y, Lichtenstein G, et al
    A Novel User-Friendly Model to Predict Corticosteroid Utilization in Newly Diagnosed Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001080.
    PubMed     Text format     Abstract available


  62. NGUYEN GC, Murthy SK, Bressler B, Lam MC, et al
    Quality of Care and Outcomes Among Hospitalized Inflammatory Bowel Disease Patients: A Multicenter Retrospective Study.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001068.
    PubMed     Text format     Abstract available


  63. NAVIGLIO S, Parentin F, Nider S, Rassu N, et al
    Ocular Involvement in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Mar 21. doi: 10.1097/MIB.0000000000001079.
    PubMed     Text format     Abstract available


  64. ISHAK WW, Pan D, Steiner AJ, Feldman E, et al
    Patient-Reported Outcomes of Quality of Life, Functioning, and GI/Psychiatric Symptom Severity in Patients with Inflammatory Bowel Disease (IBD).
    Inflamm Bowel Dis. 2017 Mar 15. doi: 10.1097/MIB.0000000000001060.
    PubMed     Text format     Abstract available


  65. ARORA Z, Mukewar S, Lopez R, Camino D, et al
    Etiopathogenesis of Nephrolithiasis in Ulcerative Colitis Patients with the Ileal Pouch Anal Anastomosis.
    Inflamm Bowel Dis. 2017 Mar 15. doi: 10.1097/MIB.0000000000001070.
    PubMed     Text format     Abstract available


  66. LIGHTNER AL, Mathis KL, Dozois EJ, Hahnsloser D, et al
    Results at Up to 30 Years After Ileal Pouch-Anal Anastomosis for Chronic Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Mar 15. doi: 10.1097/MIB.0000000000001061.
    PubMed     Text format     Abstract available


  67. KELSEN JR, Dawany N, Conrad M, Devoto M, et al
    Commentary on Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early-onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey.
    Inflamm Bowel Dis. 2017 Mar 6. doi: 10.1097/MIB.0000000000001028.
    PubMed     Text format    


  68. MACER BJ, Prady SL, Mikocka-Walus A
    Antidepressants in Inflammatory Bowel Disease: A Systematic Review.
    Inflamm Bowel Dis. 2017 Mar 6. doi: 10.1097/MIB.0000000000001059.
    PubMed     Text format     Abstract available


  69. HUANG Z, Peng K, Li X, Zhao R, et al
    Mutations in Interleukin-10 Receptor and Clinical Phenotypes in Patients with Very Early Onset Inflammatory Bowel Disease: A Chinese VEO-IBD Collaboration Group Survey.
    Inflamm Bowel Dis. 2017 Mar 6. doi: 10.1097/MIB.0000000000001058.
    PubMed     Text format     Abstract available


  70. SEXTON KA, Walker JR, Graff LA, Bernstein MT, et al
    Evidence of Bidirectional Associations Between Perceived Stress and Symptom Activity: A Prospective Longitudinal Investigation in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:473-483.
    PubMed     Text format     Abstract available


  71. HUANG Y, Dalal S, Antonopoulos D, Hubert N, et al
    Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017;23:366-378.
    PubMed     Text format     Abstract available


  72. CARLSEN K, Jakobsen C, Houen G, Kallemose T, et al
    Self-managed eHealth Disease Monitoring in Children and Adolescents with Inflammatory Bowel Disease: A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2017;23:357-365.
    PubMed     Text format     Abstract available


  73. POOJARY P, Saha A, Chauhan K, Simoes P, et al
    Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database Study.
    Inflamm Bowel Dis. 2017;23:347-356.
    PubMed     Text format     Abstract available


    February 2017
  74. CARLSEN K, Jakobsen C, Houen G, Kallemose T, et al
    Self-managed eHealth Disease Monitoring in Children and Adolescents with Inflammatory Bowel Disease: A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2017 Feb 13. doi: 10.1097/MIB.0000000000001026.
    PubMed     Text format     Abstract available


  75. POOJARY P, Saha A, Chauhan K, Simoes P, et al
    Predictors of Hospital Readmissions for Ulcerative Colitis in the United States: A National Database Study.
    Inflamm Bowel Dis. 2017 Feb 13. doi: 10.1097/MIB.0000000000001041.
    PubMed     Text format     Abstract available


  76. HUANG Y, Dalal S, Antonopoulos D, Hubert N, et al
    Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis.
    Inflamm Bowel Dis. 2017 Feb 13. doi: 10.1097/MIB.0000000000001027.
    PubMed     Text format     Abstract available


  77. BRANDSE JF, Mould D, Smeekes O, Ashruf Y, et al
    A Real-life Population Pharmacokinetic Study Reveals Factors Associated with Clearance and Immunogenicity of Infliximab in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Feb 10. doi: 10.1097/MIB.0000000000001043.
    PubMed     Text format     Abstract available


  78. KOPYLOV U, Ron Y, Avni-Biron I, Koslowsky B, et al
    Efficacy and Safety of Vedolizumab for Induction of Remission in Inflammatory Bowel Disease-the Israeli Real-World Experience.
    Inflamm Bowel Dis. 2017 Feb 7. doi: 10.1097/MIB.0000000000001039.
    PubMed     Text format     Abstract available


  79. RODRIGUEZ-PALACIOS A, Corridoni D, Di Stefano G, Di Martino L, et al
    O-014 Bacterial Sensor NOD2 Deletion Causes Th2-Inflammatory Bowel Disease Improvement Without Inducing Acute Metatranscriptomic Dysbiosis in Mice.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S5.
    PubMed     Text format     Abstract available


  80. HABERMAN Y, Ben-Shoshan M, Di-Segni A, Dexheimer P, et al
    O-009 Long ncRNA Landscape in the Ileum of Treatment Naive Early Onset Crohn Disease.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S3-S4.
    PubMed     Text format     Abstract available


  81. KIM ES, Jang BI, Kim KO, Kim EY, et al
    O-007 Impact of Education on School Nurses' Knowledge of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S3.
    PubMed     Text format     Abstract available


  82. EL-MATARY W, Samson C, Crim A, Ali S, et al
    O-006 Rapid Infliximab Infusion in Children with Inflammatory Bowel Disease: A Multi-Center North American Experience.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S2-S3.
    PubMed     Text format     Abstract available


  83. SHAKHNOVICH V, Van Haandel L, Becker M, Funk R, et al
    O-005 Combination Therapy with Methotrexate Does Not Change Infliximab Pharmacokinetics in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23 Suppl 1:S2.
    PubMed     Text format     Abstract available


  84. DUPONT-LUCAS C, Grandjean-Blanchet C, Leduc B, Tripcovici M, et al
    Prevalence and Risk Factors for Symptoms of Methotrexate Intolerance in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017;23:298-303.
    PubMed     Text format     Abstract available


  85. ALEXAKIS C, Saxena S, Chhaya V, Cecil E, et al
    Do Thiopurines Reduce the Risk of Surgery in Elderly Onset Inflammatory Bowel Disease? A 20-Year National Population-Based Cohort Study.
    Inflamm Bowel Dis. 2017 Feb 1. doi: 10.1097/MIB.0000000000001031.
    PubMed     Text format     Abstract available


    January 2017
  86. RUAN J, Chen Y, Zhou Y
    Development and Validation of a Questionnaire to Assess the Quality of Life in Patients with Inflammatory Bowel Disease in Mainland China.
    Inflamm Bowel Dis. 2017 Jan 26. doi: 10.1097/MIB.0000000000001024.
    PubMed     Text format     Abstract available


  87. FIORINO G, Manetti N, Armuzzi A, Orlando A, et al
    The PROSIT-BIO Cohort: A Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Infliximab Biosimilar.
    Inflamm Bowel Dis. 2017 Jan 12. doi: 10.1097/MIB.0000000000000995.
    PubMed     Text format     Abstract available


  88. KUCHARZIK T, Lemmnitz G, Abels C, Maaser C, et al
    Tripeptide K(D)PT Is Well Tolerated in Mild-to-moderate Ulcerative Colitis: Results from a Randomized Multicenter Study.
    Inflamm Bowel Dis. 2017 Jan 12. doi: 10.1097/MIB.0000000000001000.
    PubMed     Text format     Abstract available


  89. ABDALLA MI, Sandler RS, Kappelman MD, Martin CF, et al
    Prevalence and Impact of Inflammatory Bowel Disease-Irritable Bowel Syndrome on Patient-reported Outcomes in CCFA Partners.
    Inflamm Bowel Dis. 2017 Jan 12. doi: 10.1097/MIB.0000000000001017.
    PubMed     Text format     Abstract available


  90. QIN X
    Damage of the Mucus Layer: The Possible Shared Critical Common Cause for Both Inflammatory Bowel Disease (IBD) and Irritable Bowel Syndrome (IBS).
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001010.
    PubMed     Text format    


  91. KORELITZ BI, Shamah S
    The Ileitis of Ulcerative Colitis. Why Is It Not Crohn's Disease?
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001006.
    PubMed     Text format    


  92. SCHREINER P, Biedermann L, Rossel JB, Rogler G, et al
    Prevalence and Determinants of Job Stress in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001012.
    PubMed     Text format     Abstract available


  93. COENEN S, Weyts E, Jorissen C, De Munter P, et al
    Effects of Education and Information on Vaccination Behavior in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001013.
    PubMed     Text format     Abstract available


  94. CHEN Y, Furuya-Kanamori L, Doi SA, Ananthakrishnan AN, et al
    Clostridium difficile Infection and Risk of Colectomy in Patients with Inflammatory Bowel Disease: A Bias-adjusted Meta-analysis.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000000998.
    PubMed     Text format     Abstract available


  95. LEWIS JD, Albenberg L, Lee D, Kratz M, et al
    The Importance and Challenges of Dietary Intervention Trials for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2017 Jan 10. doi: 10.1097/MIB.0000000000001009.
    PubMed     Text format     Abstract available


    December 2016
  96. NGUYEN GC, Bernstein CN, Benchimol EI
    Risk of Surgery and Mortality in Elderly-onset Inflammatory Bowel Disease: A Population-based Cohort Study.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000000993.
    PubMed     Text format     Abstract available


  97. RUBIN DT, Feld LD, Goeppinger SR, Margolese J, et al
    The Crohn's and Colitis Foundation of America Survey of Inflammatory Bowel Disease Patient Health Care Access.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000000994.
    PubMed     Text format     Abstract available


  98. HOU JK, Kramer JR, Richardson P, Sansgiry S, et al
    Tuberculosis Screening and Reactivation Among a National Cohort of Patients with Inflammatory Bowel Disease Treated with Tumor Necrosis Factor Alpha Antagonists.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000001003.
    PubMed     Text format     Abstract available


  99. FRIEDMAN S, Larsen PV, Fedder J, Norgard BM, et al
    The Efficacy of Assisted Reproduction in Women with Inflammatory Bowel Disease and the Impact of Surgery-A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2016 Dec 16. doi: 10.1097/MIB.0000000000000996.
    PubMed     Text format     Abstract available


  100. SIVA S, Rubin DT, Gulotta G, Wroblewski K, et al
    Zinc Deficiency is Associated with Poor Clinical Outcomes in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  101. TAHARA T, Hirata I, Nakano N, Nagasaka M, et al
    Comprehensive DNA Methylation Profiling of Inflammatory Mucosa in Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  102. GRACIE DJ, Ford AC
    Ongoing Symptoms in Ulcerative Colitis Patients in Remission: Irritable Bowel Syndrome or Gastrointestinal Symptoms in the Absence of Inflammation?
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  103. HUANG C, De Ravin SS, Paul AR, Heller T, et al
    Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous Disease.
    Inflamm Bowel Dis. 2016;22:2794-2801.
    PubMed     Text format     Abstract available


    November 2016
  104. CUI DJ, Yang XL, Hu M, Yang LC, et al
    Effects of Preoperative Methotrexate on Complications After Surgery for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  105. ISHIKAWA D, Sasaki T, Osada T, Kuwahara-Arai K, et al
    Changes in Intestinal Microbiota Following Combination Therapy with Fecal Microbial Transplantation and Antibiotics for Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  106. ROBINSON AM, Gondalia SV, Karpe AV, Eri R, et al
    Fecal Microbiota and Metabolome in a Mouse Model of Spontaneous Chronic Colitis: Relevance to Human Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  107. HUANG C, De Ravin SS, Paul AR, Heller T, et al
    Genetic Risk for Inflammatory Bowel Disease Is a Determinant of Crohn's Disease Development in Chronic Granulomatous Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  108. TAKESHITA K, Mizuno S, Mikami Y, Sujino T, et al
    A Single Species of Clostridium Subcluster XIVa Decreased in Ulcerative Colitis Patients.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  109. CALDERA F, Hayney MS
    Barriers to Administration of Herpes Zoster Immunization in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:E44.
    PubMed     Text format    


  110. MOTTET C, Schoepfer AM, Juillerat P, Cosnes J, et al
    Experts Opinion on the Practical Use of Azathioprine and 6-Mercaptopurine in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2733-2747.
    PubMed     Text format     Abstract available


  111. HASHASH JG, Sigal R, Wein-Levy P, Szigethy EM, et al
    Inflammatory Bowel Disease (IBD) Connect: A Novel Volunteer Program for Hospitalized Patients with IBD and Their Families.
    Inflamm Bowel Dis. 2016;22:2748-2753.
    PubMed     Text format     Abstract available


  112. GIANOTTI RJ, Moss AC
    The Use and Efficacy of Fecal Microbiota Transplantation for Refractory Clostridium difficile in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2704-2710.
    PubMed     Text format     Abstract available


  113. REICH J, Guo L, Hall J, Tran A, et al
    A Survey of Social Media Use and Preferences in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2678-2687.
    PubMed     Text format     Abstract available


  114. COLLIJ V, Festen EA, Alberts R, Weersma RK, et al
    Drug Repositioning in Inflammatory Bowel Disease Based on Genetic Information.
    Inflamm Bowel Dis. 2016;22:2562-2570.
    PubMed     Text format     Abstract available


  115. TEW GA, Jones K, Mikocka-Walus A
    Physical Activity Habits, Limitations, and Predictors in People with Inflammatory Bowel Disease: A Large Cross-sectional Online Survey.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


    October 2016
  116. CHOY MC, Visvanathan K, De Cruz P
    An Overview of the Innate and Adaptive Immune System in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  117. BARNES EL, Burakoff R
    New Biomarkers for Diagnosing Inflammatory Bowel Disease and Assessing Treatment Outcomes.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  118. PALONE F, Vitali R, Cucchiara S, Mennini M, et al
    Fecal HMGB1 Reveals Microscopic Inflammation in Adult and Pediatric Patients with Inflammatory Bowel Disease in Clinical and Endoscopic Remission.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


    September 2016
  119. CHEN SW, Wang PY, Liu YC, Sun L, et al
    Effect of Long Noncoding RNA H19 Overexpression on Intestinal Barrier Function and Its Potential Role in the Pathogenesis of Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  120. CANEPARO V, Pastorelli L, Pisani LF, Bruni B, et al
    Distinct Anti-IFI16 and Anti-GP2 Antibodies in Inflammatory Bowel Disease and Their Variation with Infliximab Therapy.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  121. JONEFJALL B, Ohman L, Simren M, Strid H, et al
    IBS-like Symptoms in Patients with Ulcerative Colitis in Deep Remission Are Associated with Increased Levels of Serum Cytokines and Poor Psychological Well-being.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  122. QIN X
    Perinuclear Antineutrophil Cytoplasmic Antibody with a Large Portion Being Anti-beta-Glucuronidase, May Have Played a Causative Role in the Pathogenesis of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  123. ZITTAN E, Milgrom R, Ma GW, Wong-Chong N, et al
    Preoperative Anti-tumor Necrosis Factor Therapy in Patients with Ulcerative Colitis Is Not Associated with an Increased Risk of Infectious and Noninfectious Complications After Ileal Pouch-anal Anastomosis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  124. COTE-DAIGNEAULT J, Peerani F, MacMahon E, Delaporte E, et al
    Management and Prevention of Herpes Zoster in the Immunocompromised Inflammatory Bowel Disease Patient: A Clinical Quandary.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  125. CONRAD MA, Stein RE, Maxwell EC, Albenberg L, et al
    Vedolizumab Therapy in Severe Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  126. SEDGHI S, Barreau F, Morilla I, Montcuquet N, et al
    Increased Proliferation of the Ileal Epithelium as a Remote Effect of Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  127. TALABUR HORJE CS, Meijer J, Rovers L, van Lochem EG, et al
    Prevalence of Upper Gastrointestinal Lesions at Primary Diagnosis in Adults with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:E33-4.
    PubMed     Text format    


  128. NOBEL T, Khaitov S, Greenstein AJ
    Controversies in J Pouch Surgery for Ulcerative Colitis: A Focus on Handsewn Versus Stapled Anastomosis.
    Inflamm Bowel Dis. 2016;22:2302-9.
    PubMed     Text format     Abstract available


  129. ABDUL-BAKI H, Greer JB, Binion DG, Kermanshahi TR, et al
    IBD LIVE Case Series-Case 5: The Many Faces of Cytomegalovirus in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2245-54.
    PubMed     Text format    


  130. BARNES EL, Beery RM, Schulman AR, McCarthy EP, et al
    Hospitalizations for Acute Myocardial Infarction Are Decreased Among Patients with Inflammatory Bowel Disease Using a Nationwide Inpatient Database.
    Inflamm Bowel Dis. 2016;22:2229-37.
    PubMed     Text format     Abstract available


  131. LEVY RL, van Tilburg MA, Langer SL, Romano JM, et al
    Effects of a Cognitive Behavioral Therapy Intervention Trial to Improve Disease Outcomes in Children with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2134-48.
    PubMed     Text format     Abstract available


  132. SINGH N, Rabizadeh S, Jossen J, Pittman N, et al
    Multi-Center Experience of Vedolizumab Effectiveness in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:2121-6.
    PubMed     Text format     Abstract available


  133. GOFFIN L, Fagagnini S, Vicari A, Mamie C, et al
    Anti-MMP-9 Antibody: A Promising Therapeutic Strategy for Treatment of Inflammatory Bowel Disease Complications with Fibrosis.
    Inflamm Bowel Dis. 2016;22:2041-57.
    PubMed     Text format     Abstract available


    August 2016
  134. HAMILTON MJ, Makrauer FM, Golden K, Wang H, et al
    Prospective Evaluation of Terminal Ileitis in a Surveillance Population of Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  135. FISCHER M, Kao D, Kelly C, Kuchipudi A, et al
    Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  136. KOPYLOV U, Boucher G, Waterman M, Rivers CR, et al
    Genetic Predictors of Benign Course of Ulcerative Colitis-A North American Inflammatory Bowel Disease Genetics Consortium Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  137. LIM TY, Pavlidis P, Gulati S, Pirani T, et al
    Vedolizumab in Inflammatory Bowel Disease Associated with Autoimmune Liver Disease Pre- and Postliver Transplantation: A Case Series.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  138. BENCHIMOL EI, Manuel DG, Mojaverian N, Mack DR, et al
    Health Services Utilization, Specialist Care, and Time to Diagnosis with Inflammatory Bowel Disease in Immigrants to Ontario, Canada: A Population-Based Cohort Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  139. ASHTON JJ, Andreoletti G, Coelho T, Haggarty R, et al
    Identification of Variants in Genes Associated with Single-gene Inflammatory Bowel Disease by Whole-exome Sequencing.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  140. GLOVER LE, Fennimore B, Wingfield M
    Inflammatory Bowel Disease: Influence and Implications in Reproduction.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  141. LEE WJ, Briars L, Lee TA, Calip GS, et al
    Top-down Versus Step-up Prescribing Strategies for Tumor Necrosis Factor Alpha Inhibitors in Children and Young Adults with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  142. HASOSAH M, Matrafi A, Jastaniah W, Alsahafi A, et al
    Pediatric Inflammatory Bowel Disease and Hereditary Hemolytic Anemia: A Retrospective Analysis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  143. MCDANIEL DK, Eden K, Ringel VM, Allen IC, et al
    Emerging Roles for Noncanonical NF-kappaB Signaling in the Modulation of Inflammatory Bowel Disease Pathobiology.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  144. GUERRERIO AL, Frischmeyer-Guerrerio PA, Huang C, Wu Y, et al
    Increased Prevalence of Inflammatory Bowel Disease in Patients with Mutations in Genes Encoding the Receptor Subunits for TGFbeta.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  145. JACKSON WE, Achkar JP, Macaron C, Lee L, et al
    The Significance of Sessile Serrated Polyps in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  146. LI R, Zheng J, Jiang M, Liu Y, et al
    Increased Digestive Proteases and Decreased beta-Glucuronidase in Feces of Rats Treated with Sucralose and Saccharin-Another Critical Evidence That These Dietary Chemicals May Be Important Causative Factors for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:E29-30.
    PubMed     Text format    


  147. TAO Z, Qin Z
    Can Statins Be Used in Patients with Inflammatory Bowel Disease Regularly?
    Inflamm Bowel Dis. 2016;22:E28-9.
    PubMed     Text format    


  148. MATTHIS AL, Zhang B, Denson LA, Yacyshyn BR, et al
    Importance of the Evaluation of N-Acetyltransferase Enzyme Activity Prior to 5-Aminosalicylic Acid Medication for Ulcerative Colitis.
    Inflamm Bowel Dis. 2016;22:1793-802.
    PubMed     Text format     Abstract available


  149. NG SC, Leung WK, Shi HY, Li MK, et al
    Epidemiology of Inflammatory Bowel Disease from 1981 to 2014: Results from a Territory-Wide Population-Based Registry in Hong Kong.
    Inflamm Bowel Dis. 2016;22:1954-60.
    PubMed     Text format     Abstract available


  150. GOVANI SM, Wiitala WL, Stidham RW, Saini SD, et al
    Age Disparities in the Use of Steroid-sparing Therapy for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:1923-8.
    PubMed     Text format     Abstract available


  151. REIGADA LC, Satpute A, Hoogendoorn CJ, Cohen BH, et al
    Patient-reported Anxiety: A Possible Predictor of Pediatric Inflammatory Bowel Disease Health Care Use.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  152. SEVERS M, Zuithoff PN, Mangen MJ, van der Valk ME, et al
    Assessing Self-reported Medication Adherence in Inflammatory Bowel Disease: A Comparison of Tools.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  153. SU HY, Gupta V, Day AS, Gearry RB, et al
    Rising Incidence of Inflammatory Bowel Disease in Canterbury, New Zealand.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  154. HOU JK, Feagins LA, Waljee AK
    Characteristics and Behavior of Elderly-onset Inflammatory Bowel Disease: A Multi-center US Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  155. VAN ASSELDONK DP, Jharap B, Verheij J, den Hartog G, et al
    The Prevalence of Nodular Regenerative Hyperplasia in Inflammatory Bowel Disease Patients Treated with Thioguanine Is Not Associated with Clinically Significant Liver Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


    July 2016
  156. KOCHHAR G, Singh T, Dust H, Lopez R, et al
    Impact of De Novo and Preexisting Inflammatory Bowel Disease on the Outcome of Orthotopic Liver Transplantation.
    Inflamm Bowel Dis. 2016;22:1670-8.
    PubMed     Text format     Abstract available


  157. ABDUL SULTAN A, West J, Ban L, Humes D, et al
    Adverse Pregnancy Outcomes Among Women with Inflammatory Bowel Disease: A Population-Based Study from England.
    Inflamm Bowel Dis. 2016;22:1621-30.
    PubMed     Text format     Abstract available


  158. DOTSON JL, Falaiye T, Bricker JB, Strople J, et al
    North American Pediatric Gastroenterology Fellowship Needs Assessment in Inflammatory Bowel Disease: Trainee and Program Director Perspectives.
    Inflamm Bowel Dis. 2016;22:1616-20.
    PubMed     Text format     Abstract available


  159. COHEN BL, Ha C, Ananthakrishnan AN, Rieder F, et al
    State of Adult Trainee Inflammatory Bowel Disease Education in the United States: A National Survey.
    Inflamm Bowel Dis. 2016;22:1609-15.
    PubMed     Text format     Abstract available


  160. TOM MR, Li J, Ueno A, Fort Gasia M, et al
    Novel CD8+ T-Cell Subsets Demonstrating Plasticity in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22:1596-608.
    PubMed     Text format     Abstract available


  161. AFZALI A, Cross RK
    Racial and Ethnic Minorities with Inflammatory Bowel Disease in the United States: A Systematic Review of Disease Characteristics and Differences.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  162. BESSISSOW T, Le NH, Rollet K, Afif W, et al
    Incidence and Predictors of Nonalcoholic Fatty Liver Disease by Serum Biomarkers in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


    June 2016
  163. MITSUHASHI S, Feldbrugge L, Csizmadia E, Mitsuhashi M, et al
    Luminal Extracellular Vesicles (EVs) in Inflammatory Bowel Disease (IBD) Exhibit Proinflammatory Effects on Epithelial Cells and Macrophages.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  164. SCAIOLI E, Digby RJ, Belluzzi A
    Different Cutoff Levels of Fecal Calprotectin to Predict Clinical Relapse in Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  165. CONROY G, Clerc-Urmes I, Allen PB, Baumann C, et al
    What Proportion of Patients With Inflammatory Bowel Disease Want to Stop Infliximab Therapy?
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  166. LIMDI JK
    Rectal Therapy in Ulcerative Colitis: Science and Sensitivity.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  167. SMOLINSKA S, Groeger D, Perez NR, Schiavi E, et al
    Histamine Receptor 2 is Required to Suppress Innate Immune Responses to Bacterial Ligands in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  168. ALOI M, D'Arcangelo G, Bramuzzo M, Gasparetto M, et al
    Effect of Early Versus Late Azathioprine Therapy in Pediatric Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  169. PAVLIDIS P, Stamoulos P, Abdulrehman A, Kerr P, et al
    Long-term Safety and Efficacy of Low-dose Azathioprine and Allopurinol Cotherapy in Inflammatory Bowel Disease: A Large Observational Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  170. RESTALL GJ, Simms AM, Walker JR, Graff LA, et al
    Understanding Work Experiences of People with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


    May 2016
  171. GREN ST, Grip O
    Role of Monocytes and Intestinal Macrophages in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  172. LI J, Ueno A, Fort Gasia M, Luider J, et al
    Profiles of Lamina Propria T Helper Cell Subsets Discriminate Between Ulcerative Colitis and Crohn's Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  173. ANDREWS C, McLean MH, Durum SK
    Interleukin-27 as a Novel Therapy for Inflammatory Bowel Disease: A Critical Review of the Literature.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  174. SUBRAMANIAN S, Asher R, Weston W, Rimmer M, et al
    Validation of a Simple 0 to 10 Numerical Score (IBD-10) of Patient-reported Inflammatory Bowel Disease Activity for Routine Clinical Use.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  175. LOPETUSO LR, Ianiro G, Scaldaferri F, Cammarota G, et al
    Gut Virome and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  176. HUPPERTZ-HAUSS G, Lie Hoivik M, Jelsness-Jorgensen LP, Henriksen M, et al
    Health-related Quality of Life in Patients with Inflammatory Bowel Disease 20 Years After Diagnosis: Results from the IBSEN Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  177. REININK AR, Lee TC, Higgins PD
    Endoscopic Mucosal Healing Predicts Favorable Clinical Outcomes in Inflammatory Bowel Disease: A Meta-analysis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  178. RIEDER F, Cohen BL, Dotson JL, Bewtra M, et al
    Rising Educators, Academicians, and Clinicians Helping Inflammatory Bowel Disease-Promoting Improvement of Inflammatory Bowel Disease Education in the United States.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  179. HOPKINS CW, Moulton CD
    Is it Premature to Advocate Systematic Psychological Screening for Patients with Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  180. DEGRUTTOLA AK, Low D, Mizoguchi A, Mizoguchi E, et al
    Current Understanding of Dysbiosis in Disease in Human and Animal Models.
    Inflamm Bowel Dis. 2016;22:1137-50.
    PubMed     Text format     Abstract available


  181. DONEGAN A, Boyle B, Crandall W, Dotson JL, et al
    Connecting Families: A Pediatric IBD Center's Development and Implementation of a Volunteer Parent Mentor Program.
    Inflamm Bowel Dis. 2016;22:1151-6.
    PubMed     Text format     Abstract available


  182. GREENUP AJ, Bressler B, Rosenfeld G
    Medical Imaging in Small Bowel Crohn's Disease-Computer Tomography Enterography, Magnetic Resonance Enterography, and Ultrasound: "Which One Is the Best for What?".
    Inflamm Bowel Dis. 2016;22:1246-61.
    PubMed     Text format     Abstract available


  183. GANZ ML, Sugarman R, Wang R, Hansen BB, et al
    The Economic and Health-related Impact of Crohn's Disease in the United States: Evidence from a Nationally Representative Survey.
    Inflamm Bowel Dis. 2016;22:1032-41.
    PubMed     Text format     Abstract available


  184. CALABRESE E, Maaser C, Zorzi F, Kannengiesser K, et al
    Bowel Ultrasonography in the Management of Crohn's Disease. A Review with Recommendations of an International Panel of Experts.
    Inflamm Bowel Dis. 2016;22:1168-83.
    PubMed     Text format     Abstract available


  185. SEHGAL P, Colombel JF, Narula N
    Adverse Events During Anti-TNFalpha Therapies in IBD (Excluding Infections and Malignancies): When to Stop, Continue, or Switch Therapies.
    Inflamm Bowel Dis. 2016;22:1239-45.
    PubMed     Text format     Abstract available


  186. SAAD AM, Czul F, Sakuraba A, Rubin DT, et al
    Age of Diagnosis is Associated with Disease Presentation and Therapeutic Complications in Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1027-31.
    PubMed     Text format     Abstract available


  187. FLASAR MH, Chao J, Ozbay AB, Skup M, et al
    Biological and Immunomodulator Use in Crohn's Disease in a Medicaid Population.
    Inflamm Bowel Dis. 2016;22:1056-64.
    PubMed     Text format     Abstract available


  188. CHACHU KA, Osterman MT
    How to Diagnose and Treat IBD Mimics in the Refractory IBD Patient Who Does Not Have IBD.
    Inflamm Bowel Dis. 2016;22:1262-74.
    PubMed     Text format     Abstract available


  189. HAYASHI R, Tsuchiya K, Fukushima K, Horita N, et al
    Reduced Human alpha-defensin 6 in Noninflamed Jejunal Tissue of Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1119-28.
    PubMed     Text format     Abstract available


  190. INOKUCHI T, Kato J, Hiraoka S, Takashima S, et al
    Fecal Immunochemical Test Versus Fecal Calprotectin for Prediction of Mucosal Healing in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1078-85.
    PubMed     Text format     Abstract available


  191. CHEN ML, Sundrud MS
    Cytokine Networks and T-Cell Subsets in Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:1157-67.
    PubMed     Text format     Abstract available


  192. GALE G, Sigurdsson GV, Ostman S, Malmborg P, et al
    Does Crohn's Disease with Concomitant Orofacial Granulomatosis Represent a Distinctive Disease Subtype?
    Inflamm Bowel Dis. 2016;22:1071-7.
    PubMed     Text format     Abstract available


  193. LIMKETKAI BN, Parian AM, Shah ND, Colombel JF, et al
    Short Bowel Syndrome and Intestinal Failure in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1209-18.
    PubMed     Text format     Abstract available


  194. MURAWSKA N, Fabisiak A, Fichna J
    Anemia of Chronic Disease and Iron Deficiency Anemia in Inflammatory Bowel Diseases: Pathophysiology, Diagnosis, and Treatment.
    Inflamm Bowel Dis. 2016;22:1198-208.
    PubMed     Text format     Abstract available


  195. WRIGHT EK, Kamm MA, De Cruz P, Hamilton AL, et al
    Comparison of Fecal Inflammatory Markers in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:1086-94.
    PubMed     Text format     Abstract available


    April 2016
  196. MIKOCKA-WALUS A, Knowles SR, Keefer L, Graff L, et al
    Addressing Psychological Needs of Individuals with Inflammatory Bowel Disease Is Necessary.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  197. REGUEIRO MD, McAnallen SE, Greer JB, Perkins SE, et al
    The Inflammatory Bowel Disease Specialty Medical Home: A New Model of Patient-centered Care.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  198. GARRITY-PARK MM, Loftus EV Jr, Bryant SC, Smyrk TC, et al
    A Biomarker Panel to Detect Synchronous Neoplasm in Non-neoplastic Surveillance Biopsies from Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  199. SUN L, Wang W, Xiao W, Yang H, et al
    The Roles of Cathelicidin LL-37 in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  200. STEENHOLDT C, Bendtzen K, Brynskov J, Ainsworth MA, et al
    Optimizing Treatment with TNF Inhibitors in Inflammatory Bowel Disease by Monitoring Drug Levels and Antidrug Antibodies.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  201. CASALS-SEOANE F, Chaparro M, Mate J, Gisbert JP, et al
    Clinical Course of Bone Metabolism Disorders in Patients with Inflammatory Bowel Disease: A 5-Year Prospective Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  202. BIRIMBERG-SCHWARTZ L, Wilson DC, Kolho KL, Karolewska-Bochenek K, et al
    pANCA and ASCA in Children with IBD-Unclassified, Crohn's Colitis, and Ulcerative Colitis-A Longitudinal Report from the IBD Porto Group of ESPGHAN.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  203. HEYBELI C
    The Complement System and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  204. RAO K, Higgins PD
    Epidemiology, Diagnosis, and Management of Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  205. NGUYEN GC, Croitoru K, Silverberg MS, Steinhart AH, et al
    Use of Complementary and Alternative Medicine for Inflammatory Bowel Disease Is Associated with Worse Adherence to Conventional Therapy: The COMPLIANT Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  206. YAMMINE S, Nyilas S, Casaulta C, Schibli S, et al
    Function and Ventilation of Large and Small Airways in Children and Adolescents with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  207. OPSTELTEN JL, Leenders M, Dik VK, Chan SS, et al
    Dairy Products, Dietary Calcium, and Risk of Inflammatory Bowel Disease: Results From a European Prospective Cohort Investigation.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  208. WEISSHOF R, Ungar B, Blatt A, Dahan A, et al
    Anti-infliximab Antibodies with Neutralizing Capacity in Patients with Inflammatory Bowel Disease: Distinct Clinical Implications Revealed by a Novel Assay.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  209. COBURN LA, Horst SN, Allaman MM, Brown CT, et al
    L-Arginine Availability and Metabolism Is Altered in Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  210. JOHNSON DH, Taylor WR, Aboelsoud MM, Foote PH, et al
    DNA Methylation and Mutation of Small Colonic Neoplasms in Ulcerative Colitis and Crohn's Colitis: Implications for Surveillance.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  211. JANECKE AR, Heinz-Erian P, Muller T
    Mechanisms Underlying Dysregulation of Electrolyte Absorption in Inflammatory Bowel Disease-Associated Diarrhea.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  212. YAGI S, Abe M, Yamashita M, Mori K, et al
    Carbonic Anhydrate I Epitope Peptide Improves Inflammation in a Murine Model of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  213. MANETTI N, Bagnoli S, Rogai F, Bonanomi AG, et al
    Disease Course and Colectomy Rate of Ulcerative Colitis: A Follow-up Cohort Study of a Referral Center in Tuscany.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  214. BIANCHERI P, Foster MR, Fyfe MC, MacDonald TT, et al
    Effect of Narrow Spectrum Versus Selective Kinase Inhibitors on the Intestinal Proinflammatory Immune Response in Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  215. AL-HUSSAINI A, El Mouzan M, Hasosah M, Al-Mehaidib A, et al
    Clinical Pattern of Early-Onset Inflammatory Bowel Disease in Saudi Arabia: A Multicenter National Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  216. LI J, Wei Z, Chang X, Cardinale CJ, et al
    Pathway-based Genome-wide Association Studies Reveal the Association Between Growth Factor Activity and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  217. MESTROVIC T
    Leveling the Human Microbiota Playing Field: A Rederivation of Gut Bacteria to Human Cells Ratio in Physiological Conditions and in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  218. WU W, Chen F, Liu Z, Cong Y, et al
    Microbiota-specific Th17 Cells: Yin and Yang in Regulation of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  219. QIN X
    How Sugar and Soft Drinks Are Related to Inflammatory Bowel Disease?
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  220. HORJUS TALABUR HORJE CS, Meijer J, Rovers L, van Lochem EG, et al
    Prevalence of Upper Gastrointestinal Lesions at Primary Diagnosis in Adults with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  221. HERRERA-DEGUISE C, Casellas F, Robles V, Navarro E, et al
    Iron Deficiency in the Absence of Anemia Impairs the Perception of Health-Related Quality of Life of Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  222. AFZALI A, Park CJ, Zhu K, Hu JK, et al
    Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  223. DEVLIN SM, Melmed GY, Irving PM, Rubin DT, et al
    Recommendations for Quality Colonoscopy Reporting for Patients with Inflammatory Bowel Disease: Results from a RAND Appropriateness Panel.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  224. WASAN SK, Zullow S, Berg A, Cheifetz AS, et al
    Herpes Zoster Vaccine Response in Inflammatory Bowel Disease Patients on Low-dose Immunosuppression.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  225. BUCHNER AM, Lichtenstein GR
    How to Assess and Document Endoscopies in IBD Patients by Including Standard Scoring Systems.
    Inflamm Bowel Dis. 2016;22:1010-9.
    PubMed     Text format     Abstract available


  226. GILS A, Van Stappen T, Dreesen E, Storme R, et al
    Harmonization of Infliximab and Anti-Infliximab Assays Facilitates the Comparison Between Originators and Biosimilars in Clinical Samples.
    Inflamm Bowel Dis. 2016;22:969-75.
    PubMed     Text format     Abstract available


  227. DUBINSKY MC, Rosh J, Faubion WA Jr, Kierkus J, et al
    Efficacy and Safety of Escalation of Adalimumab Therapy to Weekly Dosing in Pediatric Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:886-93.
    PubMed     Text format     Abstract available


  228. KAUR M, Panikkath D, Yan X, Liu Z, et al
    Perianal Crohn's Disease is Associated with Distal Colonic Disease, Stricturing Disease Behavior, IBD-Associated Serologies and Genetic Variation in the JAK-STAT Pathway.
    Inflamm Bowel Dis. 2016;22:862-9.
    PubMed     Text format     Abstract available


  229. VERGARA M, Sicilia B, Prieto L, Casellas F, et al
    Development and Validation of the Short Crohn's Disease Work Disability Questionnaire.
    Inflamm Bowel Dis. 2016;22:955-62.
    PubMed     Text format     Abstract available


  230. JUNG ES, Cheon JH, Lee JH, Park SJ, et al
    HLA-C*01 is a Risk Factor for Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:796-806.
    PubMed     Text format     Abstract available


  231. MA C, Beilman CL, Huang VW, Fedorak DK, et al
    Anti-TNF Therapy Within 2 Years of Crohn's Disease Diagnosis Improves Patient Outcomes: A Retrospective Cohort Study.
    Inflamm Bowel Dis. 2016;22:870-9.
    PubMed     Text format     Abstract available


    March 2016
  232. QIN X
    Is Colonic Crohn's Disease More Closely Related to Ulcerative Colitis or Crohn's Disease by Nature?
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  233. QIN X
    The Possible Link Between Artificial Sweeteners Such as Saccharin and Sucralose and Inflammatory Bowel Disease Deserves Further Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  234. GEISZ M, Ha C, Kappelman MD, Martin CF, et al
    Medication Utilization and the Impact of Continued Corticosteroid Use on Patient-reported Outcomes in Older Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  235. BRANDSE JF, Bennink RJ, van Eeden S, Lowenberg M, et al
    Performance of Common Disease Activity Markers as a Reflection of Inflammatory Burden in Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  236. KOH SZ, Zaghiyan KN, Li Q, Rabizadeh S, et al
    Clinical Factors Associated with the Development of Crohn's Disease in Inflammatory Bowel Disease-unclassified Patients Undergoing Ileal Pouch-anal Anastomosis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  237. TYLER AD, Kirsch R, Milgrom R, Stempak JM, et al
    Microbiome Heterogeneity Characterizing Intestinal Tissue and Inflammatory Bowel Disease Phenotype.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  238. HUGHES M, Qazi T, Berg A, Weinberg J, et al
    Host Immune Response to Clostridium difficile Infection in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  239. CAO SS
    Epithelial ER Stress in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  240. CLICK B, Ramos Rivers C, Koutroubakis IE, Babichenko D, et al
    Demographic and Clinical Predictors of High Healthcare Use in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  241. THOMPSON KD, Connor SJ, Walls DM, Gollins J, et al
    Patients with Ulcerative Colitis Are More Concerned About Complications of Their Disease than Side Effects of Medications.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  242. WU F, Huang Y, Dong F, Kwon JH, et al
    Ulcerative Colitis-Associated Long Noncoding RNA, BC012900, Regulates Intestinal Epithelial Cell Apoptosis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  243. FORBES JD, Van Domselaar G, Bernstein CN
    Microbiome Survey of the Inflamed and Noninflamed Gut at Different Compartments Within the Gastrointestinal Tract of Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  244. SIMIAN D, Flores L, Ibanez P, Figueroa C, et al
    O-025 Disease-Related Knowledge in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22 Suppl 1:S9.
    PubMed     Text format     Abstract available


  245. MORGAN P, Siegle L, Huggins J
    O-024 Improving Pneumococcal Immunization Rates Among Immunocompromised Adolescent Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22 Suppl 1:S8-S9.
    PubMed     Text format     Abstract available


  246. MCBRIDE R
    O-023 YI Impact of Dedicated Inflammatory Bowel Disease (IBD) Clinic on IBD-Related Hospitalizations at Veterans Hospital.
    Inflamm Bowel Dis. 2016;22 Suppl 1:S8.
    PubMed     Text format     Abstract available


  247. PLANTZ K, Maxwell E, Mamula P, Baldassano R, et al
    O-022 Intravenous Iron Sucrose for Treatment of Iron Deficiency Anemia in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22 Suppl 1:S8.
    PubMed     Text format     Abstract available


  248. GRANT A, Kappelman M, Martin C, Otley A, et al
    O-021 A New Domain Structure for the IMPACT-III, a Pediatric Inflammatory Bowel Disease (IBD) Health Reported Quality of Life (HRQOL) Tool.
    Inflamm Bowel Dis. 2016;22 Suppl 1:S7-S8.
    PubMed     Text format     Abstract available


  249. VIENNOIS E, Zhao Y, Zhang M, Han M, et al
    O-016 YI Longitudinal Study of Circulating miRNA Biomarkers in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016;22 Suppl 1:S6.
    PubMed     Text format     Abstract available


  250. JEURING SF, van den Heuvel TR, Zeegers MP, Hameeteman WH, et al
    Epidemiology and Long-term Outcome of Inflammatory Bowel Disease Diagnosed at Elderly Age-An Increasing Distinct Entity?
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  251. ANANTHAKRISHNAN AN, Cagan A, Cai T, Gainer VS, et al
    Comparative Effectiveness of Infliximab and Adalimumab in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  252. GUERRA I, Perez-Jeldres T, Iborra M, Algaba A, et al
    Incidence, Clinical Characteristics, and Management of Psoriasis Induced by Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  253. WOLF DC
    Biosimilars in Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  254. BHASIN S, Singh H, Targownik LE, Israeli E, et al
    Rates and Reasons for Nonuse of Prescription Medication for Inflammatory Bowel Disease in a Referral Clinic.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  255. MIKOCKA-WALUS A, Knowles SR, Keefer L, Graff L, et al
    Controversies Revisited: A Systematic Review of the Comorbidity of Depression and Anxiety with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:752-62.
    PubMed     Text format     Abstract available


  256. WITTEN J, Siles R, Shen B, Yao Q, et al
    Triple Disease Combination: Familial Mediterranean Fever, Crohn's Disease, and Chronic Idiopathic Urticaria with Angioedema.
    Inflamm Bowel Dis. 2016;22:E12-3.
    PubMed     Text format    


  257. KRUGLIAK CLEVELAND N, Colman RJ, Rodriquez D, Hirsch A, et al
    Surveillance of IBD Using High Definition Colonoscopes Does Not Miss Adenocarcinoma in Patients with Low-grade Dysplasia.
    Inflamm Bowel Dis. 2016;22:631-7.
    PubMed     Text format     Abstract available


  258. KJELDSEN J, Nielsen J, Larsen MD, Qvist N, et al
    Postoperative Use of Anti-TNF-alpha Agents in Patients with Crohn's Disease and Risk of Reoperation-A Nationwide Cohort Study.
    Inflamm Bowel Dis. 2016;22:599-606.
    PubMed     Text format     Abstract available


  259. ROY A, Lichtiger S
    Clostridium difficile Infection: A Rarity in Patients Receiving Chronic Antibiotic Treatment for Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:648-53.
    PubMed     Text format     Abstract available


  260. CARRIERE J, Bretin A, Darfeuille-Michaud A, Barnich N, et al
    Exosomes Released from Cells Infected with Crohn's Disease-associated Adherent-Invasive Escherichia coli Activate Host Innate Immune Responses and Enhance Bacterial Intracellular Replication.
    Inflamm Bowel Dis. 2016;22:516-28.
    PubMed     Text format     Abstract available


  261. CLEYNEN I, Konings P, Robberecht C, Laukens D, et al
    Genome-Wide Copy Number Variation Scan Identifies Complement Component C4 as Novel Susceptibility Gene for Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:505-15.
    PubMed     Text format     Abstract available


  262. CHOI SH, Kim KW, Lee JY, Kim KJ, et al
    Diffusion-weighted Magnetic Resonance Enterography for Evaluating Bowel Inflammation in Crohn's Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2016;22:669-79.
    PubMed     Text format     Abstract available


  263. SAMAAN MA, de Jong D, Sahami S, Morgan S, et al
    Incidence and Severity of Prepouch Ileitis: A Distinct Disease Entity or a Manifestation of Refractory Pouchitis?
    Inflamm Bowel Dis. 2016;22:662-8.
    PubMed     Text format     Abstract available


    February 2016
  264. GAIDOS JK, Bickston SJ
    How to Optimize Colon Cancer Surveillance in Inflammatory Bowel Disease Patients.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  265. SHAPIRO JM, Zoega H, Shah SA, Bright RM, et al
    Incidence of Crohn's Disease and Ulcerative Colitis in Rhode Island: Report from the Ocean State Crohn's and Colitis Area Registry.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  266. ROSA A, Abrantes P, Sousa I, Francisco V, et al
    Ulcerative Colitis Is Under Dual (Mitochondrial and Nuclear) Genetic Control.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  267. LIN JC, Lin CS, Hsu CW, Lin CL, et al
    Association Between Parkinson's Disease and Inflammatory Bowel Disease: a Nationwide Taiwanese Retrospective Cohort Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  268. THEEDE K, Holck S, Ibsen P, Kallemose T, et al
    Fecal Calprotectin Predicts Relapse and Histological Mucosal Healing in Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  269. POULLENOT F, Seksik P, Beaugerie L, Amiot A, et al
    Risk of Incident Cancer in Inflammatory Bowel Disease Patients Starting Anti-TNF Therapy While Having Recent Malignancy.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  270. PRINCE AC, Myers CE, Joyce T, Irving P, et al
    Fermentable Carbohydrate Restriction (Low FODMAP Diet) in Clinical Practice Improves Functional Gastrointestinal Symptoms in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  271. ALEXOFF A, Roginsky G, Zhou Y, Kalenda M, et al
    Inpatient Costs for Patients with Inflammatory Bowel Disease and Acute Pancreatitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  272. GUO L, Reich J, Groshek J, Farraye FA, et al
    Social Media Use in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  273. SKOWRON KB, Lapin B, Rubin M, Hurst RD, et al
    Clostridium Difficile Infection in Ulcerative Colitis: Can Alteration of the Gut-associated Microbiome Contribute to Pouch Failure?
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  274. KAO CC, Lin CL, Huang WY, Cha TL, et al
    Association Between Inflammatory Bowel Disease and Erectile Dysfunction: A Nationwide Population-Based Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  275. LIMDI JK, Aggarwal D, McLaughlin JT
    Diet and Exacerbation of Inflammatory Bowel Disease Symptoms-Food for Thought.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  276. ROSEN D, Annunziato R, Colombel JF, Dubinsky M, et al
    Transition of Inflammatory Bowel Disease Care: Assessment of Transition Readiness Factors and Disease Outcomes in a Young Adult Population.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  277. DULAI PS, Singh S, Casteele NV, Boland BS, et al
    How Will Evolving Future Therapies and Strategies Change How We Position the Use of Biologics in Moderate to Severely Active Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  278. SEVERS M, Petersen RE, Siersema PD, Mangen MJ, et al
    Self-reported Health Care Utilization of Patients with Inflammatory Bowel Disease Correlates Perfectly with Medical Records.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  279. BHARADWAJ S, Shen B
    Therapeutic Armamentarium for Stricturing Crohn's Disease: Medical Versus Endoscopic Versus Surgical Approaches.
    Inflamm Bowel Dis. 2016;22:E7-8.
    PubMed     Text format    


  280. ALASTRUEY CL, Andujar Murcia X, Esteve Comas M
    Therapeutic Armamentarium for Stricturing Crohn's Disease: Medical Versus Endoscopic Versus Surgical Approaches.
    Inflamm Bowel Dis. 2016;22:E6.
    PubMed     Text format    


  281. MONIF GR
    Translation of Hypothesis to Therapy in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:E8-9.
    PubMed     Text format    


  282. WALTER JG, Kahn SA, Noe JD, Schurman JV, et al
    Feeling Fine: Anxiety and Depressive Symptoms in Youth with Established IBD.
    Inflamm Bowel Dis. 2016;22:402-8.
    PubMed     Text format     Abstract available


  283. MIKOCKA-WALUS A, Andrews JM, Bampton P
    Cognitive Behavioral Therapy for IBD.
    Inflamm Bowel Dis. 2016;22:E5-6.
    PubMed     Text format    


  284. SORRENTINO D
    Preclinical and Undiagnosed Crohn's Disease: The Submerged Iceberg.
    Inflamm Bowel Dis. 2016;22:476-86.
    PubMed     Text format     Abstract available


  285. HARRIS KA, Horst S, Gadani A, Nohl A, et al
    Patients with Refractory Crohn's Disease Successfully Treated with Ustekinumab.
    Inflamm Bowel Dis. 2016;22:397-401.
    PubMed     Text format     Abstract available


  286. GRAY WN, Maddux MH
    Current Transition Practices in Pediatric IBD: Findings from a National Survey of Pediatric Providers.
    Inflamm Bowel Dis. 2016;22:372-9.
    PubMed     Text format     Abstract available


  287. DUCHATELLIER CF, Kumar R, Krupoves A, Braegger C, et al
    Steroid Administration and Growth Impairment in Children with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:355-63.
    PubMed     Text format     Abstract available


  288. NAFTALI T, Reshef L, Kovacs A, Porat R, et al
    Distinct Microbiotas are Associated with Ileum-Restricted and Colon-Involving Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:293-302.
    PubMed     Text format     Abstract available


  289. OCHOA-CORTES F, Turco F, Linan-Rico A, Soghomonyan S, et al
    Enteric Glial Cells: A New Frontier in Neurogastroenterology and Clinical Target for Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:433-49.
    PubMed     Text format     Abstract available


  290. SUNADA K, Shinozaki S, Nagayama M, Yano T, et al
    Long-term Outcomes in Patients with Small Intestinal Strictures Secondary to Crohn's Disease After Double-balloon Endoscopy-assisted Balloon Dilation.
    Inflamm Bowel Dis. 2016;22:380-6.
    PubMed     Text format     Abstract available


  291. MENYS A, Makanyanga J, Plumb A, Bhatnagar G, et al
    Aberrant Motility in Unaffected Small Bowel is Linked to Inflammatory Burden and Patient Symptoms in Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:424-32.
    PubMed     Text format     Abstract available


  292. GAWRON LM, Sanders J, Steele KP, Flynn AD, et al
    Reproductive Planning and Contraception for Women with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:459-64.
    PubMed     Text format     Abstract available


  293. GOLAN D, Gross B, Miller A, Klil-Drori S, et al
    Cognitive Function of Patients with Crohn's Disease is Associated with Intestinal Disease Activity.
    Inflamm Bowel Dis. 2016;22:364-71.
    PubMed     Text format     Abstract available


    January 2016
  294. LEE HS, Park SH, Kim SH, Kim J, et al
    Risk Factors and Clinical Outcomes Associated with Cytomegalovirus Colitis in Patients with Acute Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  295. ZITTAN E, Kelly OB, Kirsch R, Milgrom R, et al
    Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  296. PROSBERG MV, Vester-Andersen MK, Andersson M, Jess T, et al
    Long-term Compliance with Oral 5-aminosalicylic Acid Therapy and Risk of Disease Recurrence in Patients with Ulcerative Colitis: A Population-based Cohort Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  297. SANTOS-ANTUNES J, Nunes AC, Lopes S, Macedo G, et al
    The Relevance of Vitamin D and Antinuclear Antibodies in Patients with Inflammatory Bowel Disease Under Anti-TNF Treatment: A Prospective Study.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  298. REED-KNIGHT B, Lee JL, Greenley RN, Lewis JD, et al
    Disease Activity Does Not Explain It All: How Internalizing Symptoms and Caregiver Depressive Symptoms Relate to Health-related Quality of Life Among Youth with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  299. SHAH ED, Siegel CA, Chong K, Melmed GY, et al
    Evaluating Study Withdrawal Among Biologics and Immunomodulators in Treating Ulcerative Colitis: A Meta-analysis of Controlled Clinical Trials.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  300. COTE-DAIGNEAULT J, Mehandru S, Ungaro R, Atreja A, et al
    Potential Immunomodulatory Effects of Statins in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  301. EPPINGA H, Peppelenbosch MP
    Worsening of Bowel Symptoms Through Diet in Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  302. AGUAS M, Del Hoyo J, Faubel R, Nos P, et al
    Telemedicine in Inflammatory Bowel Disease: Opportunity Ahead.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format    


  303. YARUR AJ, Jain A, Hauenstein SI, Quintero MA, et al
    Higher Adalimumab Levels Are Associated with Histologic and Endoscopic Remission in Patients with Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  304. BERES NJ, Szabo D, Kocsis D, Szucs D, et al
    Role of Altered Expression of miR-146a, miR-155, and miR-122 in Pediatric Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  305. CARROLL MW, Hamilton Z, Gill H, Simkin J, et al
    Pediatric Inflammatory Bowel Disease Among South Asians Living in British Columbia, Canada: A Distinct Clinical Phenotype.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  306. PIERDOMENICO M, Cesi V, Cucchiara S, Vitali R, et al
    NOD2 Is Regulated By Mir-320 in Physiological Conditions but this Control Is Altered in Inflamed Tissues of Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  307. NISHIDA A, Hidaka K, Kanda T, Imaeda H, et al
    Increased Expression of Interleukin-36, a Member of the Interleukin-1 Cytokine Family, in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2016.
    PubMed     Text format     Abstract available


  308. BETTENWORTH D, Rieder F
    Reversibility of Stricturing Crohn's Disease-Fact or Fiction?
    Inflamm Bowel Dis. 2016;22:241-7.
    PubMed     Text format     Abstract available


  309. VAZEILLE E, Chassaing B, Buisson A, Dubois A, et al
    GipA Factor Supports Colonization of Peyer's Patches by Crohn's Disease-associated Escherichia Coli.
    Inflamm Bowel Dis. 2016;22:68-81.
    PubMed     Text format     Abstract available


  310. HERFARTH HH, Kappelman MD, Long MD, Isaacs KL, et al
    Use of Methotrexate in the Treatment of Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2016;22:224-33.
    PubMed     Text format     Abstract available


  311. MCCONNELL RA, Mahadevan U
    Use of Immunomodulators and Biologics Before, During, and After Pregnancy.
    Inflamm Bowel Dis. 2016;22:213-23.
    PubMed     Text format     Abstract available


  312. REICH KM, Fedorak RN, Madsen K, Kroeker KI, et al
    Role of Vitamin D in Infliximab-induced Remission in Adult Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2016;22:92-9.
    PubMed     Text format     Abstract available


  313. MANCINA RM, Spagnuolo R, Milano M, Brogneri S, et al
    PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes.
    Inflamm Bowel Dis. 2016;22:134-40.
    PubMed     Text format     Abstract available


  314. ZUO L, Li Y, Zhu W, Shen B, et al
    Mesenteric Adipocyte Dysfunction in Crohn's Disease is Associated with Hypoxia.
    Inflamm Bowel Dis. 2016;22:114-26.
    PubMed     Text format     Abstract available


    December 2015
  315. TAMBUWALA MM
    Natural Nuclear Factor Kappa Beta Inhibitors: Safe Therapeutic Options for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  316. THARIAN B, George N, Navaneethan U
    Endoscopy in the Diagnosis and Management of Complications of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  317. SPOENDLIN J, Karatas G, Furlano RI, Jick SS, et al
    Rosacea in Patients with Ulcerative Colitis and Crohn's Disease: A Population-based Case-control Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  318. RACINE A, Carbonnel F, Chan SS, Hart AR, et al
    Dietary Patterns and Risk of Inflammatory Bowel Disease in Europe: Results from the EPIC Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  319. HOURIGAN SK, Sears CL, Oliva-Hemker M
    Clostridium difficile Infection in Pediatric Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  320. WINTER R, Norgard BM, Friedman S
    Treatment of the Pregnant Patient with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  321. KAPLAN M, Yuksel M, Ates I, Yaln Kilic ZM, et al
    Are sTWEAK and IL-17A Levels in Inflammatory Bowel Disease Associated with Disease Activity and Etiopathogenesis?
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  322. SUNSERI WM, Kugathasan S, Keljo DJ, Greer JB, et al
    IBD LIVE Case Series-Case 3: Very Early-Onset Inflammatory Bowel Disease: When Genetic Testing Proves Beneficial.
    Inflamm Bowel Dis. 2015;21:2958-2968.
    PubMed     Text format    


  323. ISAACS KL, Arora S
    Navigating the Affordable Care Act and the Patient with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015;21:2969-74.
    PubMed     Text format     Abstract available


  324. PRIYAMVADA S, Gomes R, Gill RK, Saksena S, et al
    Mechanisms Underlying Dysregulation of Electrolyte Absorption in Inflammatory Bowel Disease-Associated Diarrhea.
    Inflamm Bowel Dis. 2015;21:2926-35.
    PubMed     Text format     Abstract available


  325. HIEJIMA E, Nakase H, Heike T
    Reply: To PMID 25946569.
    Inflamm Bowel Dis. 2015;21:E30-1.
    PubMed     Text format    


    November 2015
  326. LASCURAIN L, Jensen MK, Guthery SL, Holmen J, et al
    Inflammatory Bowel Disease Phenotype in Pediatric Primary Sclerosing Cholangitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  327. LONG MD, Weaver K, Kappelman MD, Herfarth HH, et al
    Photosensitivity to Ultraviolet Light in Patients with Inflammatory Bowel Disease Newly Initiating Immunosuppressive Therapy.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  328. AHN HS
    Reply to: Food Additives Should Not be Ruled Out as the Possible Causative Factors of Inflammatory Bowel Disease in Korea.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  329. TORMEY LK, Farraye FA, PaascheOrlow MK
    Understanding Health Literacy and its Impact on Delivering Care to Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  330. AHMED S, Melmed G, McGovern D, Robbins LA, et al
    Nonbloody Diarrhea but Not Significant Weight Loss at Diagnosis Is Associated with the Development of Denovo Crohn's Disease After Ileal Pouch-anal Anastomosis for Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  331. DEBRUYN J, Fonseca K, Ghosh S, Panaccione R, et al
    Immunogenicity of Influenza Vaccine for Patients with Inflammatory Bowel Disease on Maintenance Infliximab Therapy: A Randomized Trial.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  332. LOPEZ-SILES M, Martinez-Medina M, Suris-Valls R, Aldeguer X, et al
    Changes in the Abundance of Faecalibacterium prausnitzii Phylogroups I and II in the Intestinal Mucosa of Inflammatory Bowel Disease and Patients with Colorectal Cancer.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  333. SANDS BE, Joshi S, Haddad J, Freudenberg JM, et al
    Assessing Colonic Exposure, Safety, and Clinical Activity of SRT2104, a Novel Oral SIRT1 Activator, in Patients with Mild to Moderate Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  334. QIN X
    Food Additives Should Not Be Ruled Out as the Possible Causative Factors of Inflammatory Bowel Disease in Korea.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  335. HINKS TS
    Reduced Numbers and Proapoptotic Features of Mucosal-associated Invariant T Cells as a Characteristic Finding in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  336. CHANDE N, Marshall JK, Seow CH, Sandborn WJ, et al
    New Applications for Traditional Drugs in Inflammatory Bowel Disease: What Do Cochrane Reviews Tell Us?
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  337. SRINATH AI, Gupta N, Husain SZ
    Probing the Association of Pancreatitis in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  338. VINDING KK, Elsberg H, Thorkilgaard T, Belard E, et al
    Fecal Calprotectin Measured By Patients at Home Using Smartphones-A New Clinical Tool in Monitoring Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  339. GISBERT JP, Barreiro-de Acosta M, Esteve M, Garcia-Sanchez V, et al
    Physician Perspectives on Unresolved Issues in the Management of Ulcerative Colitis: The UC Horizons Project.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  340. NEILSON K, Ftanou M, Monshat K, Salzberg M, et al
    A Controlled Study of a Group Mindfulness Intervention for Individuals Living With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  341. ZELMAN-TOISTER E, Bakos E, Cohen S, Zigmond E, et al
    CD151 Regulates T-Cell Migration in Health and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  342. SARTINI A, Di Girolamo M, Bertani A, Villa E, et al
    "Blindly" ADA Dose Escalation to 80 mg Weekly in Crohn's Disease Patients with LOR: Is It Cost Effective or Not?
    Inflamm Bowel Dis. 2015;21:E27-8.
    PubMed     Text format    


    October 2015
  343. UHLIG HH, Schwerd T
    From Genes to Mechanisms: The Expanding Spectrum of Monogenic Disorders Associated with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  344. FIGUEIREDO VC, Markworth JF, Durainayagam BR, Pileggi CA, et al
    Impaired Ribosome Biogenesis and Skeletal Muscle Growth in a Murine Model of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  345. PUTIGNANI L, Del Chierico F, Vernocchi P, Cicala M, et al
    Gut Microbiota Dysbiosis as Risk and Premorbid Factors of IBD and IBS Along the Childhood-Adulthood Transition.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  346. BITTON A, Vutcovici M, Sewitch M, Suissa S, et al
    Mortality Trends in Crohn's Disease and Ulcerative Colitis: A Population-based Study in Quebec, Canada.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  347. SASAKI MM, Skol AD, Hungate EA, Bao R, et al
    Whole-exome Sequence Analysis Implicates Rare Il17REL Variants in Familial and Sporadic Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  348. DESILETS M, Deng X, Rao C, Ensminger AW, et al
    Genome-based Definition of an Inflammatory Bowel Disease-associated Adherent-Invasive Escherichia coli Pathovar.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


    September 2015
  349. GERBARG PL, Jacob VE, Stevens L, Bosworth BP, et al
    The Effect of Breathing, Movement, and Meditation on Psychological and Physical Symptoms and Inflammatory Biomarkers in Inflammatory Bowel Disease: A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  350. SHAH SL, Siegel CA
    Increasing Patient Activation Could Improve Outcomes for Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  351. HOLUBAR SD, Holder-Murray J, Flasar M, Lazarev M, et al
    Anti-Tumor Necrosis Factor-alpha Antibody Therapy Management Before and After Intestinal Surgery for Inflammatory Bowel Disease: A CCFA Position Paper.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  352. JANSE IC, Koldijk MJ, Spekhorst LM, Vila AV, et al
    Identification of Clinical and Genetic Parameters Associated with Hidradenitis Suppurativa in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  353. YE BD, Choi H, Hong M, Yun WJ, et al
    Identification of Ten Additional Susceptibility Loci for Ulcerative Colitis Through Immunochip Analysis in Koreans.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  354. MAKKAR R, Graff LA, Bharadwaj S, Lopez R, et al
    Psychological Factors in Irritable Pouch Syndrome and Other Pouch Disorders.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  355. LIMDI JK, Aggarwal D, McLaughlin JT
    Dietary Practices and Beliefs in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  356. MCCOMBIE A, Gearry R, Andrews J, Mulder R, et al
    Does Computerized Cognitive Behavioral Therapy Help People with Inflammatory Bowel Disease? A Randomized Controlled Trial.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  357. HERMAN ML, Kane SV
    Treatment Nonadherence in Inflammatory Bowel Disease: Identification, Scope, and Management Strategies.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  358. ROSEN DJ, Dubinsky MC
    The Evolving Role of Thiopurines for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  359. KOUTROUBAKIS IE, Regueiro M, Schoen RE, Ramos-Rivers C, et al
    Multiyear Patterns of Serum Inflammatory Biomarkers and Risk of Colorectal Neoplasia in Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  360. PENNINCK E, Fumery M, Armengol-Debeir L, Sarter H, et al
    Postoperative Complications in Pediatric Inflammatory Bowel Disease: A Population-based Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  361. HOVDE O, Smastuen MC, Hoivik ML, Bernklev T, et al
    Mortality and Causes of Death in Ulcerative Colitis: Results from 20 Years of Follow-up in the IBSEN Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  362. JOOSSE ME, Samsom JN, van der Woude CJ, Escher JC, et al
    The Role of Therapeutic Drug Monitoring of Anti-Tumor Necrosis Factor Alpha Agents in Children and Adolescents with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015;21:2214-21.
    PubMed     Text format     Abstract available


  363. GREGORI D
    Reply to Are Worries and Concerns Information Side Effects?
    Inflamm Bowel Dis. 2015;21:E23.
    PubMed     Text format    


  364. BERROA E, Fernandez-Salazar L, Rodriguez McCullough N, Garrote Adrados JA, et al
    Are Worries and Concerns Information Side Effects?
    Inflamm Bowel Dis. 2015;21:E22.
    PubMed     Text format    


    August 2015
  365. GIBSON DJ, Elliott L, McDermott E, Tosetto M, et al
    Heightened Expression of CD39 by Regulatory T Lymphocytes Is Associated with Therapeutic Remission in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  366. ANANTHAKRISHNAN AN, Cagan A, Cai T, Gainer VS, et al
    Identification of Nonresponse to Treatment Using Narrative Data in an Electronic Health Record Inflammatory Bowel Disease Cohort.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  367. LEE AJ, Kraemer DF, Smotherman C, Eid E, et al
    Providing Our Fellows in Training with Education on Inflammatory Bowel Disease Health Maintenance to Improve the Quality of Care in Our Health Care System.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  368. LEE KK, Jharap B, Maser EA, Colombel JF, et al
    Impact of Concomitant Endometriosis on Phenotype and Natural History of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  369. CRISTOBAL I, Manso R, Gonzalez-Alonso P, Madoz-Gurpide J, et al
    Clinical Value of miR-26b Discriminating Ulcerative Colitis-associated Colorectal Cancer in the Subgroup of Patients with Metastatic Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  370. O'CONNOR A, Packey CD, Akbari M, Moss AC, et al
    Mesalamine, but Not Sulfasalazine, Reduces the Risk of Colorectal Neoplasia in Patients with Inflammatory Bowel Disease: An Agent-specific Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  371. HASHASH JG, Chintamaneni P, Ramos Rivers CM, Koutroubakis IE, et al
    Patterns of Antibiotic Exposure and Clinical Disease Activity in Inflammatory Bowel Disease: A 4-year Prospective Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  372. TRIER MOLLER F, Andersen V, Andersson M, Jess T, et al
    Hospital Admissions, Biological Therapy, and Surgery in Familial and Sporadic Cases of Inflammatory Bowel Disease: A Population-Based Cohort Study 1977-2011.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  373. VALENTINO PL, Feldman BM, Walters TD, Griffiths AM, et al
    Abnormal Liver Biochemistry Is Common in Pediatric Inflammatory Bowel Disease: Prevalence and Associations.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  374. MCCURDY JD, Enders FT, Jones A, Killian JM, et al
    Detection of Cytomegalovirus in Patients with Inflammatory Bowel Disease: Where to Biopsy and How Many Biopsies?
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  375. SLEVIN SM, Egan LJ
    New Insights into the Mechanisms of Action of Anti-Tumor Necrosis Factor-alpha Monoclonal Antibodies in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  376. DEL PINTO R, Pietropaoli D, Chandar AK, Ferri C, et al
    Association Between Inflammatory Bowel Disease and Vitamin D Deficiency: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  377. STALLHOFER J, Friedrich M, Konrad-Zerna A, Wetzke M, et al
    Lipocalin-2 Is a Disease Activity Marker in Inflammatory Bowel Disease Regulated by IL-17A, IL-22, and TNF-alpha and Modulated by IL23R Genotype Status.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  378. BOLLEN L, Vande Casteele N, Peeters M, Van Assche G, et al
    The Occurrence of Thrombosis in Inflammatory Bowel Disease Is Reflected in the Clot Lysis Profile.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  379. POLYTARCHOU C, Oikonomopoulos A, Mahurkar S, Touroutoglou A, et al
    Assessment of Circulating MicroRNAs for the Diagnosis and Disease Activity Evaluation in Patients with Ulcerative Colitis by Using the Nanostring Technology.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  380. BOYLE M, Ting A, Cury DB, Nanda K, et al
    Adherence to Rectal Mesalamine in Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  381. VANHOVE W, Peeters PM, Staelens D, Schraenen A, et al
    Strong Upregulation of AIM2 and IFI16 Inflammasomes in the Mucosa of Patients with Active Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  382. LEAL MC, Dabritz J
    Immunoregulatory Role of Myeloid-derived Cells in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  383. YAMAMOTO-FURUSHO JK, Fonseca-Camarillo G
    Genetic Markers Associated with Clinical Outcomes in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  384. DITISHEIM S, Fournier N, Juillerat P, Pittet V, et al
    Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  385. ALLEGRETTI JR, Borges L, Lucci M, Chang M, et al
    Risk Factors for Rehospitalization Within 90 Days in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  386. MONAGHAN TM, Cockayne A, Mahida YR
    Pathogenesis of Clostridium difficile Infection and Its Potential Role in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015;21:1957-1966.
    PubMed     Text format     Abstract available


  387. SHEN J, Mao AP, Zhu MM, Zhao P, et al
    Ulcerative Colitis Database: An Integrated Database and Toolkit for Gene Function and Medication Involved in Ulcerative Colitis.
    Inflamm Bowel Dis. 2015;21:1872-1882.
    PubMed     Text format     Abstract available


  388. HUTH K, Benchimol EI, Aglipay M, Mack DR, et al
    Strategies to Improve Influenza Vaccination in Pediatric Inflammatory Bowel Disease Through Education and Access.
    Inflamm Bowel Dis. 2015;21:1761-1768.
    PubMed     Text format     Abstract available


  389. BOUSVAROS A
    Thalidomide Treatment of Pediatric Ulcerative Colitis: A New Use for an Old Drug.
    Inflamm Bowel Dis. 2015;21:1750-1751.
    PubMed     Text format    


  390. GASHIN L, Cheifetz AS
    Reply to Use of CT Scan in Ulcerative Colitis Patients Presenting to the Emergency Department.
    Inflamm Bowel Dis. 2015;21:E21.
    PubMed     Text format    


  391. SEMINERIO JL, Koutroubakis IE, Ramos-Rivers C, Hashash JG, et al
    Impact of Obesity on the Management and Clinical Course of Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  392. STIDHAM RW, Waljee AK, Day NM, Bergmans CL, et al
    Reply to Body Fat Composition Predicts Infectious Complications After Bowel Resection in Crohn's Disease.
    Inflamm Bowel Dis. 2015;21:E19-20.
    PubMed     Text format    


  393. LI Y, Zhu W
    Body Fat Composition Predicts Infectious Complications After Bowel Resection in Crohn's Disease.
    Inflamm Bowel Dis. 2015;21:E19.
    PubMed     Text format    


    July 2015
  394. ANANTHAKRISHNAN AN, Khalili H, Song M, Higuchi LM, et al
    High School Diet and Risk of Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  395. DAVE M, Mehta K, Luther J, Baruah A, et al
    Mesenchymal Stem Cell Therapy for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  396. FULLER-THOMSON E, West KJ, Sulman J, Baird SL, et al
    Childhood Maltreatment Is Associated with Ulcerative Colitis but Not Crohn's Disease: Findings from a Population-based Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  397. RISPO A, Testa A, De Palma GD, Donetto S, et al
    Different Profile of Efficacy of Thiopurines in Ulcerative Colitis and Crohn's Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  398. GREENLEY RN, Gumidyala AP, Nguyen E, Plevinsky JM, et al
    Can You Teach a Teen New Tricks? Problem Solving Skills Training Improves Oral Medication Adherence in Pediatric Patients with Inflammatory Bowel Disease Participating in a Randomized Trial.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  399. DOSHI-VELEZ F, Avillach P, Palmer N, Bousvaros A, et al
    Prevalence of Inflammatory Bowel Disease Among Patients with Autism Spectrum Disorders.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  400. FULLER-THOMSON E, Lateef R, Sulman J
    Robust Association Between Inflammatory Bowel Disease and Generalized Anxiety Disorder: Findings from a Nationally Representative Canadian Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  401. SHUKLA T, Singh S, Loftus EV Jr, Bruining DH, et al
    Antiviral Therapy in Steroid-refractory Ulcerative Colitis with Cytomegalovirus: Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  402. GOREN I, Yahav L, Tulchinsky H, Dotan I, et al
    Serology of Patients with Ulcerative Colitis After Pouch Surgery Is More Comparable with that of Patients with Crohn's Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  403. KINNUCAN J, Tomal J, Rubin DT
    U.S. Patients with Ulcerative Colitis Do Not Have a Decreased Risk of Diverticulosis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  404. CHEN P, Bakke D, Kolodziej L, Lodolce J, et al
    Antrum Mucosal Protein-18 Peptide Targets Tight Junctions to Protect and Heal Barrier Structure and Function in Models of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  405. KINI AT, Thangaraj KR, Simon E, Shivappagowdar A, et al
    Aberrant Niche Signaling in the Etiopathogenesis of Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  406. HENAO MP, Bewtra M, Osterman MT, Aberra FN, et al
    Measurement of Inflammatory Bowel Disease Symptoms: Reliability of an Abbreviated Approach to Data Collection.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  407. PEREIRA C, Gracio D, Teixeira JP, Magro F, et al
    Oxidative Stress and DNA Damage: Implications in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  408. WATERMAN M, Knight J, Dinani A, Xu W, et al
    Predictors of Outcome in Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  409. JABEEN R, Miller L, Yao W, Gupta S, et al
    Altered STAT4 Isoform Expression in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  410. MANES G, Fontana P, de Nucci G, Radaelli F, et al
    Colon Cleansing for Colonoscopy in Patients with Ulcerative Colitis: Efficacy and Acceptability of a 2-L PEG Plus Bisacodyl Versus 4-L PEG.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  411. VESTER-ANDERSEN MK, Prosberg MV, Vind I, Andersson M, et al
    Low Risk of Unemployment, Sick Leave, and Work Disability Among Patients with Inflammatory Bowel Disease: A 7-year Follow-up Study of a Danish Inception Cohort.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  412. CHIA R, Borum ML
    African Americans May Access the Emergency Department for Inflammatory Bowel Disease Care More Often than Whites.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  413. NABI S
    Use of CT Scan in Ulcerative Colitis Patients Presenting to the Emergency Department.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  414. VAVRICKA SR, Schoepfer A, Scharl M, Lakatos PL, et al
    Extraintestinal Manifestations of Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  415. MORENO-RINCON E, Benitez JM, Serrano-Ruiz FJ, Vazquez-Moron JM, et al
    Prognosis of Patients with Ulcerative Colitis in Sustained Remission After Thiopurines Withdrawal.
    Inflamm Bowel Dis. 2015;21:1564-71.
    PubMed     Text format     Abstract available



  416. Elevated IL-13Ra2 in Intestinal Epithelial Cells From Ulcerative Colitis or Colorectal Cancer Initiates MAPK Pathway: RETRACTION.
    Inflamm Bowel Dis. 2015;21:1736.
    PubMed     Text format    


  417. EHRENPREIS ED, Habib I, Mazulis A, Roginsky G, et al
    Reply to Morse and Sartor.
    Inflamm Bowel Dis. 2015;21:E12.
    PubMed     Text format    


  418. ZAND A, van Deen WK, Inserra EK, Hall L, et al
    Presenteeism in Inflammatory Bowel Diseases: A Hidden Problem with Significant Economic Impact.
    Inflamm Bowel Dis. 2015;21:1623-30.
    PubMed     Text format     Abstract available


  419. PARAMSOTHY S, Borody TJ, Lin E, Finlayson S, et al
    Donor Recruitment for Fecal Microbiota Transplantation.
    Inflamm Bowel Dis. 2015;21:1600-6.
    PubMed     Text format     Abstract available


  420. CERRILLO E, Beltran B, Pous S, Echarri A, et al
    Fecal Calprotectin in Ileal Crohn's Disease: Relationship with Magnetic Resonance Enterography and a Pathology Score.
    Inflamm Bowel Dis. 2015;21:1572-9.
    PubMed     Text format     Abstract available


  421. KOBOZIEV I, Jones-Hall Y, Valentine JF, Webb CR, et al
    Use of Humanized Mice to Study the Pathogenesis of Autoimmune and Inflammatory Diseases.
    Inflamm Bowel Dis. 2015;21:1652-73.
    PubMed     Text format     Abstract available


  422. WIESE DM, Beaulieu D, Slaughter JC, Horst S, et al
    Use of Endoscopic Ultrasound to Guide Adalimumab Treatment in Perianal Crohn's Disease Results in Faster Fistula Healing.
    Inflamm Bowel Dis. 2015;21:1594-9.
    PubMed     Text format     Abstract available


  423. GRAY WN, Resmini AR, Baker KD, Holbrook E, et al
    Concerns, Barriers, and Recommendations to Improve Transition from Pediatric to Adult IBD Care: Perspectives of Patients, Parents, and Health Professionals.
    Inflamm Bowel Dis. 2015;21:1641-51.
    PubMed     Text format     Abstract available


  424. SARO C, Ceballos D, Munoz F, De la Coba C, et al
    Resources Utilization and Costs the Year Before and After Starting Treatment with Adalimumab in Crohn's Disease Patients.
    Inflamm Bowel Dis. 2015;21:1631-40.
    PubMed     Text format     Abstract available


  425. HIEJIMA E, Kawai T, Nakase H, Tsuruyama T, et al
    Reduced Numbers and Proapoptotic Features of Mucosal-associated Invariant T Cells as a Characteristic Finding in Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015;21:1529-40.
    PubMed     Text format     Abstract available


  426. PILLET S, Jarlot C, Courault M, Del Tedesco E, et al
    Infliximab Does Not Worsen Outcomes During Flare-ups Associated with Cytomegalovirus Infection in Patients with Ulcerative Colitis.
    Inflamm Bowel Dis. 2015;21:1580-6.
    PubMed     Text format     Abstract available


  427. YARUR AJ, Rubin DT
    Therapeutic Drug Monitoring of Anti-tumor Necrosis Factor Agents in Patients with Inflammatory Bowel Diseases.
    Inflamm Bowel Dis. 2015;21:1709-18.
    PubMed     Text format     Abstract available


  428. CHANDAR AK, Singh S, Murad MH, Peyrin-Biroulet L, et al
    Efficacy and Safety of Natalizumab and Vedolizumab for the Management of Crohn's Disease: A Systematic Review and Meta-analysis.
    Inflamm Bowel Dis. 2015;21:1695-708.
    PubMed     Text format     Abstract available


  429. FLANAGAN PK, Chiewchengchol D, Wright HL, Edwards SW, et al
    Killing of Escherichia coli by Crohn's Disease Monocyte-derived Macrophages and Its Enhancement by Hydroxychloroquine and Vitamin D.
    Inflamm Bowel Dis. 2015;21:1499-510.
    PubMed     Text format     Abstract available


    June 2015
  430. PEDERSEN N, Munkholm P
    Methodological Approach to Mesalazine Treatment in Patients with Mild-to-moderate Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  431. KHALILI H, Chan AT
    Reply to Comments on Measures of Obesity and Risk of Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  432. AHN HS
    Increased Incidence of Inflammatory Bowel Disease in Korea May Not Be Explained by Food Additives.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  433. MENDALL M, Chan D, Kumar D
    Comments on Measures of Obesity and Risk of Crohn's Disease and Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  434. FONSECA-CAMARILLO G, Yamamoto-Furusho JK
    Immunoregulatory Pathways Involved in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  435. QIN X
    How to Explain the Dramatic Increase Around 2000 but Recent Leveling Off of Inflammatory Bowel Disease in Korea?
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  436. MURTHY SK, Greenberg GR, Croitoru K, Nguyen GC, et al
    Extent of Early Clinical Response to Infliximab Predicts Long-term Treatment Success in Active Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  437. MCCOMBIE AM, Mulder RT, Gearry RB
    Coping Strategies and Psychological Outcomes of Patients with Inflammatory Bowel Disease in the First 6 Months After Diagnosis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  438. GOTTLIEB K, Travis S, Feagan B, Hussain F, et al
    Central Reading of Endoscopy Endpoints in Inflammatory Bowel Disease Trials.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  439. BENDERSKA N, Dittrich AL, Knaup S, Rau TT, et al
    miRNA-26b Overexpression in Ulcerative Colitis-associated Carcinogenesis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  440. CHEHOUD C, Albenberg LG, Judge C, Hoffmann C, et al
    Fungal Signature in the Gut Microbiota of Pediatric Patients With Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  441. AGILLI M, Dogan T, Ergin G
    Methodological Approach to Mesalazine Treatment in Patients with Mild-to-moderate Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  442. HOLDER-MURRAY J, Marsicovetere P, Holubar SD
    Minimally invasive surgery for inflammatory bowel disease.
    Inflamm Bowel Dis. 2015;21:1443-58.
    PubMed     Text format     Abstract available


  443. BOYNTON K, Flynn A, Box T, Dalpiaz A, et al
    Inflammatory bowel disease education: I can hear the extension for community healthcare outcomes.
    Inflamm Bowel Dis. 2015;21:1407-8.
    PubMed     Text format    


  444. KIM SY, Park SH
    Reply to What is the Role of Diffusion-weighted Imaging in Ileocolonic Crohn's Disease?
    Inflamm Bowel Dis. 2015;21:E9-E10.
    PubMed     Text format    


  445. BUISSON A, Hordonneau C, Goutte M, Bommelaer G, et al
    What is the Role of Diffusion-weighted Imaging in Ileocolonic Crohn's Disease?
    Inflamm Bowel Dis. 2015;21:E9.
    PubMed     Text format    


  446. SUSKIND DL
    Reply to can fecal microbial transplant effectively treat Crohn's disease?
    Inflamm Bowel Dis. 2015;21:E8.
    PubMed     Text format    


  447. DAI C, Jiang M, Sun MJ
    Can fecal microbial transplant effectively treat Crohn's disease?
    Inflamm Bowel Dis. 2015;21:E8.
    PubMed     Text format    


  448. HUANG VW, Prosser C, Kroeker KI, Wang H, et al
    Knowledge of Fecal Calprotectin and Infliximab Trough Levels Alters Clinical Decision-making for IBD Outpatients on Maintenance Infliximab Therapy.
    Inflamm Bowel Dis. 2015;21:1359-67.
    PubMed     Text format     Abstract available


  449. BERNSTEIN CN, Garland A, Peschken CA, Hitchon CA, et al
    Predictors of ICU Admission and Outcomes 1 Year Post-Admission in Persons with IBD: A Population-based Study.
    Inflamm Bowel Dis. 2015;21:1341-7.
    PubMed     Text format     Abstract available


  450. PANACCIONE R, Sandborn WJ, Gordon GL, Lee SD, et al
    Briakinumab for treatment of Crohn's disease: results of a randomized trial.
    Inflamm Bowel Dis. 2015;21:1329-40.
    PubMed     Text format     Abstract available


  451. BRAMHALL M, Florez-Vargas O, Stevens R, Brass A, et al
    Quality of methods reporting in animal models of colitis.
    Inflamm Bowel Dis. 2015;21:1248-59.
    PubMed     Text format     Abstract available


  452. LE PN, Greer JB, Oikonomou I, Schraut WH, et al
    IBD LIVE Case Series-Case 2: Previous Cancer in a Patient with Crohn's Disease: Is It Appropriate to Use Biologics and Immunosuppressants for IBD Treatment?
    Inflamm Bowel Dis. 2015;21:1401-6.
    PubMed     Text format    


  453. WANG W, Jovel J, Halloran B, Wine E, et al
    Metagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteria.
    Inflamm Bowel Dis. 2015;21:1419-27.
    PubMed     Text format     Abstract available


  454. LISSNER D, Schumann M, Batra A, Kredel LI, et al
    Monocyte and M1 Macrophage-induced Barrier Defect Contributes to Chronic Intestinal Inflammation in IBD.
    Inflamm Bowel Dis. 2015;21:1297-305.
    PubMed     Text format     Abstract available


  455. DE VALLIERE C, Wang Y, Eloranta JJ, Vidal S, et al
    G Protein-coupled pH-sensing Receptor OGR1 Is a Regulator of Intestinal Inflammation.
    Inflamm Bowel Dis. 2015;21:1269-81.
    PubMed     Text format     Abstract available


  456. ZUBIN G, Peter L
    Predicting Endoscopic Crohn's Disease Activity Before and After Induction Therapy in Children: A Comprehensive Assessment of PCDAI, CRP, and Fecal Calprotectin.
    Inflamm Bowel Dis. 2015;21:1386-91.
    PubMed     Text format     Abstract available


  457. WRIGHT EK, Kamm MA, Teo SM, Inouye M, et al
    Recent advances in characterizing the gastrointestinal microbiome in Crohn's disease: a systematic review.
    Inflamm Bowel Dis. 2015;21:1219-28.
    PubMed     Text format     Abstract available


  458. STIDHAM RW, Waljee AK, Day NM, Bergmans CL, et al
    Body fat composition assessment using analytic morphomics predicts infectious complications after bowel resection in Crohn's disease.
    Inflamm Bowel Dis. 2015;21:1306-13.
    PubMed     Text format     Abstract available


  459. SZIGETHY E, Youk AO, Gonzalez-Heydrich J, Bujoreanu SI, et al
    Effect of 2 psychotherapies on depression and disease activity in pediatric Crohn's disease.
    Inflamm Bowel Dis. 2015;21:1321-8.
    PubMed     Text format     Abstract available


  460. CHANG MI, Cohen BL, Greenstein AJ
    A review of the impact of biologics on surgical complications in Crohn's disease.
    Inflamm Bowel Dis. 2015;21:1472-7.
    PubMed     Text format     Abstract available


  461. SINH P, Shen B
    Endoscopic evaluation of surgically altered bowel in patients with inflammatory bowel diseases.
    Inflamm Bowel Dis. 2015;21:1459-71.
    PubMed     Text format     Abstract available


    May 2015
  462. FEUERSTEIN JD, Jiang ZG, Belkin E, Lewandowski JJ, et al
    Surgery for Ulcerative Colitis Is Associated with a High Rate of Readmissions at 30 Days.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  463. COHEN RD, Dalal SR
    Systematic Review: Rectal Therapies for the Treatment of Distal Forms of Ulcerative Colitis.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  464. VAVRICKA SR, Rogler G, Gantenbein C, Spoerri M, et al
    Chronological Order of Appearance of Extraintestinal Manifestations Relative to the Time of IBD Diagnosis in the Swiss Inflammatory Bowel Disease Cohort.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  465. LAZZERINI M, Martelossi S, Ventura A
    Thalidomide Treatment of Pediatric Ulcerative Colitis: A New Use for an Old Drug.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format    


  466. BENNIKE TB, Carlsen TG, Ellingsen T, Bonderup OK, et al
    Neutrophil Extracellular Traps in Ulcerative Colitis: A Proteome Analysis of Intestinal Biopsies.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  467. GONDIM FA, de Oliveira GR, Teles BC, Aquino PS, et al
    Clinical and Electrodiagnostic Findings in Patients with Peripheral Neuropathy and Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  468. BOOTZ F, Schmid AS, Neri D
    Alternatively Spliced EDA Domain of Fibronectin Is a Target for Pharmacodelivery Applications in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  469. MERKLEY SA, Beaulieu DB, Horst S, Duley C, et al
    Use of Intravenous Immunoglobulin for Patients with Inflammatory Bowel Disease with Contraindications or Who Are Unresponsive to Conventional Treatments.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  470. CHERFANE CE, Gessel L, Cirillo D, Zimmerman MB, et al
    Monocytosis and a Low Lymphocyte to Monocyte Ratio Are Effective Biomarkers of Ulcerative Colitis Disease Activity.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  471. VIENNOIS E, Zhao Y, Merlin D
    Biomarkers of Inflammatory Bowel Disease: From Classical Laboratory Tools to Personalized Medicine.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  472. LEE HS, Yang SK, Soh JS, Lee S, et al
    Short- and Long-Term Outcomes of Acute Severe Ulcerative Colitis in Korea: The 1999-2005 Cohort.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  473. KOUTSOCHRISTOU V, Zellos A, Dimakou K, Panayotou I, et al
    Dental Caries and Periodontal Disease in Children and Adolescents with Inflammatory Bowel Disease: A Case-Control Study.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  474. DEZFOLI S, Horton HA, Thepyasuwan N, Berel D, et al
    Combined Immunosuppression Impairs Immunogenicity to Tetanus and Pertussis Vaccination Among Patients with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  475. MELESSE DY, Targownik LE, Singh H, Blanchard JF, et al
    Patterns and Predictors of Long-term Nonuse of Medical Therapy Among Persons with Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  476. LONG MD, Gulati A, Wohl D, Herfarth H, et al
    Immunizations in Pediatric and Adult Patients with Inflammatory Bowel Disease: A Practical Case-based Approach.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  477. ALRUBAIY L, Rikaby I, Sageer M, Hutchings HA, et al
    Systematic Review of the Clinical Disease Severity Indices for Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  478. DAI C, Jiang M, Sun MJ
    Can fecal calprotection identify postoperative recurrence of Crohn's disease?
    Inflamm Bowel Dis. 2015;21:E7.
    PubMed     Text format    


  479. QIU Y
    Reply to can fecal calprotection identify postoperative recurrence of Crohn's disease?
    Inflamm Bowel Dis. 2015;21:E7.
    PubMed     Text format    


  480. WRIGHT EK, Kamm MA
    Impact of drug therapy and surgery on quality of life in Crohn's disease: a systematic review.
    Inflamm Bowel Dis. 2015;21:1187-94.
    PubMed     Text format     Abstract available


  481. LEE MN, Kang B, Choi SY, Kim MJ, et al
    Relationship between azathioprine dosage, 6-thioguanine nucleotide levels, and therapeutic response in pediatric patients with IBD treated with azathioprine.
    Inflamm Bowel Dis. 2015;21:1054-62.
    PubMed     Text format     Abstract available


  482. WHITEOAK SR, Felwick R, Sanchez-Elsner T, Fraser Cummings JR, et al
    MicroRNAs in inflammatory bowel diseases: paradoxes and possibilities.
    Inflamm Bowel Dis. 2015;21:1160-5.
    PubMed     Text format     Abstract available


  483. BOUGUEN G, Laharie D, Nancey S, Hebuterne X, et al
    Efficacy and safety of adalimumab 80 mg weekly in luminal Crohn's disease.
    Inflamm Bowel Dis. 2015;21:1047-53.
    PubMed     Text format     Abstract available


  484. DOTSON JL, Bashaw H, Nwomeh B, Crandall WV, et al
    Management of intra-abdominal abscesses in children with Crohn's disease: a 12-year, retrospective single-center review.
    Inflamm Bowel Dis. 2015;21:1109-14.
    PubMed     Text format     Abstract available


  485. HUANG EY, Inoue T, Leone VA, Dalal S, et al
    Using corticosteroids to reshape the gut microbiome: implications for inflammatory bowel diseases.
    Inflamm Bowel Dis. 2015;21:963-72.
    PubMed     Text format     Abstract available


  486. LEWIS A, Nijhuis A, Mehta S, Kumagai T, et al
    Intestinal fibrosis in Crohn's disease: role of microRNAs as fibrogenic modulators, serum biomarkers, and therapeutic targets.
    Inflamm Bowel Dis. 2015;21:1141-50.
    PubMed     Text format     Abstract available


  487. PAPA A, Papa V, Marzo M, Scaldaferri F, et al
    Prevention and treatment of venous thromboembolism in patients with IBD: a trail still climbing.
    Inflamm Bowel Dis. 2015;21:1204-13.
    PubMed     Text format     Abstract available


    April 2015
  488. LAZZERINI M, Martelossi S, Magazzu G, Pellegrino S, et al
    Effect of Thalidomide on Clinical Remission in Children and Adolescents with Ulcerative Colitis Refractory to Other Immunosuppressives: Pilot Randomized Clinical Trial.
    Inflamm Bowel Dis. 2015.
    PubMed     Text format     Abstract available


  489. SOH JS, Yun WJ, Kim KJ, Won CH, et al
    Concomitant use of azathioprine/6-mercaptopurine decreases the risk of anti-TNF-induced skin lesions.
    Inflamm Bowel Dis. 2015;21:832-9.
    PubMed     Text format     Abstract available


  490. HOLMES EA, Xiang F, Lucas RM
    Variation in incidence of pediatric Crohn's disease in relation to latitude and ambient ultraviolet radiation: a systematic review and analysis.
    Inflamm Bowel Dis. 2015;21:809-17.
    PubMed     Text format     Abstract available


  491. SCHWARTZ DA, Ghazi LJ, Regueiro M
    Guidelines for medical treatment of Crohn's perianal fistulas: critical evaluation of therapeutic trials.
    Inflamm Bowel Dis. 2015;21:737-52.
    PubMed     Text format    


  492. ONG EM, Ghazi LJ, Schwartz DA, Mortele KJ, et al
    Guidelines for imaging of Crohn's perianal fistulizing disease.
    Inflamm Bowel Dis. 2015;21:731-6.
    PubMed     Text format    


  493. SCHWARTZ DA, Ghazi LJ, Regueiro M, Fichera A, et al
    Guidelines for the multidisciplinary management of Crohn's perianal fistulas: summary statement.
    Inflamm Bowel Dis. 2015;21:723-30.
    PubMed     Text format    


  494. DOTSON JL, Kappelman MD, Chisolm DJ, Crandall WV, et al
    Racial disparities in readmission, complications, and procedures in children with Crohn's disease.
    Inflamm Bowel Dis. 2015;21:801-8.
    PubMed     Text format     Abstract available


  495. FICHERA A, Zoccali M
    Guidelines for the surgical treatment of Crohn's perianal fistulas.
    Inflamm Bowel Dis. 2015;21:753-8.
    PubMed     Text format    


  496. GRIGORAS CA, Ziakas PD, Jayamani E, Mylonakis E, et al
    ATG16L1 and IL23R variants and genetic susceptibility to crohn's disease: mode of inheritance based on meta-analysis of genetic association studies.
    Inflamm Bowel Dis. 2015;21:768-76.
    PubMed     Text format     Abstract available


  497. FALVEY JD, Hoskin T, Meijer B, Ashcroft A, et al
    Disease activity assessment in IBD: clinical indices and biomarkers fail to predict endoscopic remission.
    Inflamm Bowel Dis. 2015;21:824-31.
    PubMed     Text format     Abstract available


  498. KEVANS D, Turpin W, Madsen K, Meddings J, et al
    Determinants of intestinal permeability in healthy first-degree relatives of individuals with Crohn's disease.
    Inflamm Bowel Dis. 2015;21:879-87.
    PubMed     Text format     Abstract available


  499. SHARMA S, Eckert D, Hyams JS, Mensing S, et al
    Pharmacokinetics and exposure-efficacy relationship of adalimumab in pediatric patients with moderate to severe Crohn's disease: results from a randomized, multicenter, phase-3 study.
    Inflamm Bowel Dis. 2015;21:783-92.
    PubMed     Text format     Abstract available


  500. LIU S, Zhang Y, Ren J, Li J, et al
    Microbial DNA recognition by cGAS-STING and other sensors in dendritic cells in inflammatory bowel diseases.
    Inflamm Bowel Dis. 2015;21:901-11.
    PubMed     Text format     Abstract available


    March 2015
  501. MATALON S, Elad H, Brazowski E, Santo E, et al
    Serum alpha-1 antitrypsin: a noninvasive marker of pouchitis.
    Inflamm Bowel Dis. 2015;21:589-95.
    PubMed     Text format     Abstract available


  502. KURAHARA LH, Sumiyoshi M, Aoyagi K, Hiraishi K, et al
    Intestinal myofibroblast TRPC6 channel may contribute to stenotic fibrosis in Crohn's disease.
    Inflamm Bowel Dis. 2015;21:496-506.
    PubMed     Text format     Abstract available


  503. SUSKIND DL, Brittnacher MJ, Wahbeh G, Shaffer ML, et al
    Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease.
    Inflamm Bowel Dis. 2015;21:556-63.
    PubMed     Text format     Abstract available


  504. BOUGUEN G, Sninsky C, Tang KL, Colombel JF, et al
    Change in erythrocyte mean corpuscular volume during combination therapy with azathioprine and infliximab is associated with mucosal healing: a post hoc analysis from SONIC.
    Inflamm Bowel Dis. 2015;21:606-14.
    PubMed     Text format     Abstract available


  505. BIANCONE L, Onali S, Petruzziello C, Calabrese E, et al
    Cancer and immunomodulators in inflammatory bowel diseases.
    Inflamm Bowel Dis. 2015;21:674-98.
    PubMed     Text format     Abstract available


  506. WASILEWSKI A, Storr M, Zielinska M, Fichna J, et al
    Role of G protein-coupled orphan receptors in intestinal inflammation: novel targets in inflammatory bowel diseases.
    Inflamm Bowel Dis. 2015;21:666-73.
    PubMed     Text format     Abstract available


  507. KANI HT, Shen B
    Male issues of the ileal pouch.
    Inflamm Bowel Dis. 2015;21:716-22.
    PubMed     Text format     Abstract available


    February 2015
  508. BOSCHETTI G, Garnero P, Moussata D, Cuerq C, et al
    Accuracies of serum and fecal S100 proteins (calprotectin and calgranulin C) to predict the response to TNF antagonists in patients with Crohn's disease.
    Inflamm Bowel Dis. 2015;21:331-6.
    PubMed     Text format     Abstract available


  509. ASSA A, Vong L, Pinnell LJ, Rautava J, et al
    Vitamin D deficiency predisposes to adherent-invasive Escherichia coli-induced barrier dysfunction and experimental colonic injury.
    Inflamm Bowel Dis. 2015;21:297-306.
    PubMed     Text format     Abstract available


  510. KHARE V, Dammann K, Asboth M, Krnjic A, et al
    Overexpression of PAK1 promotes cell survival in inflammatory bowel diseases and colitis-associated cancer.
    Inflamm Bowel Dis. 2015;21:287-96.
    PubMed     Text format     Abstract available


  511. SINGH T, Levine AP, Smith PJ, Smith AM, et al
    Characterization of expression quantitative trait loci in the human colon.
    Inflamm Bowel Dis. 2015;21:251-6.
    PubMed     Text format     Abstract available


  512. CHHAYA V, Saxena S, Cecil E, Subramanian V, et al
    Impact of timing and duration of thiopurine treatment on first perianal surgery in Crohn's disease: UK population-based study (1995-2009).
    Inflamm Bowel Dis. 2015;21:385-91.
    PubMed     Text format     Abstract available


  513. QIU Y, Mao R, Chen BL, He Y, et al
    Fecal calprotectin for evaluating postoperative recurrence of Crohn's disease: a meta-analysis of prospective studies.
    Inflamm Bowel Dis. 2015;21:315-22.
    PubMed     Text format     Abstract available


  514. ZITOMERSKY NL, Atkinson BJ, Fournier K, Mitchell PD, et al
    Antibodies to infliximab are associated with lower infliximab levels and increased likelihood of surgery in pediatric IBD.
    Inflamm Bowel Dis. 2015;21:307-14.
    PubMed     Text format     Abstract available


  515. SIVIGNON A, de Vallee A, Barnich N, Denizot J, et al
    Saccharomyces cerevisiae CNCM I-3856 prevents colitis induced by AIEC bacteria in the transgenic mouse model mimicking Crohn's disease.
    Inflamm Bowel Dis. 2015;21:276-86.
    PubMed     Text format     Abstract available


  516. FRANCESCONE R, Hou V, Grivennikov SI
    Cytokines, IBD, and colitis-associated cancer.
    Inflamm Bowel Dis. 2015;21:409-18.
    PubMed     Text format     Abstract available


  517. BOLAND BS, Boyle DL, Sandborn WJ, Firestein GS, et al
    Validation of gene expression biomarker analysis for biopsy-based clinical trials in Crohn's disease.
    Inflamm Bowel Dis. 2015;21:323-30.
    PubMed     Text format     Abstract available


  518. ZIELINSKA M, Jarmuz A, Wasilewski A, Salaga M, et al
    Role of transient receptor potential channels in intestinal inflammation and visceral pain: novel targets in inflammatory bowel diseases.
    Inflamm Bowel Dis. 2015;21:419-27.
    PubMed     Text format     Abstract available


  519. BRESSENOT A, Peyrin-Biroulet L
    Histologic features predicting postoperative Crohn's disease recurrence.
    Inflamm Bowel Dis. 2015;21:468-75.
    PubMed     Text format     Abstract available


  520. ROGLER G, Vavricka S
    Exposome in IBD: recent insights in environmental factors that influence the onset and course of IBD.
    Inflamm Bowel Dis. 2015;21:400-8.
    PubMed     Text format     Abstract available


  521. KALMAN RS, Hartshorn K, Farraye FA
    Does a personal or family history of malignancy preclude the use of immunomodulators and biologics in IBD.
    Inflamm Bowel Dis. 2015;21:428-35.
    PubMed     Text format     Abstract available


  522. AMIN J, Huang B, Yoon J, Shih DQ, et al
    Update 2014: advances to optimize 6-mercaptopurine and azathioprine to reduce toxicity and improve efficacy in the management of IBD.
    Inflamm Bowel Dis. 2015;21:445-52.
    PubMed     Text format     Abstract available


    January 2015
  523. PEYRIN-BIROULET L
    Clinical remission as defined by the Mayo Score: do we deceive ourselves?
    Inflamm Bowel Dis. 2015;21:E2-3.
    PubMed     Text format    


  524. SAMAAN MA, Feagan BG, Sandborn WJ, Levesque BG, et al
    Clinical remission as defined by the Mayo Score: do we deceive ourselves?
    Inflamm Bowel Dis. 2015;21:E3-4.
    PubMed     Text format    


  525. THAPA SD
    IBD and extent of coronary atherosclerosis.
    Inflamm Bowel Dis. 2015;21:E1.
    PubMed     Text format    


  526. OPIPARI A, Franchi L
    Role of inflammasomes in intestinal inflammation and Crohn's disease.
    Inflamm Bowel Dis. 2015;21:173-81.
    PubMed     Text format     Abstract available


  527. KOPYLOV U, Nemeth A, Koulaouzidis A, Makins R, et al
    Small bowel capsule endoscopy in the management of established Crohn's disease: clinical impact, safety, and correlation with inflammatory biomarkers.
    Inflamm Bowel Dis. 2015;21:93-100.
    PubMed     Text format     Abstract available


  528. SELVAGGI F, Pellino G, Canonico S, Sciaudone G, et al
    Effect of preoperative biologic drugs on complications and function after restorative proctocolectomy with primary ileal pouch formation: systematic review and meta-analysis.
    Inflamm Bowel Dis. 2015;21:79-92.
    PubMed     Text format     Abstract available


  529. LOBATON T, Hoffman I, Vermeire S, Ferrante M, et al
    Aeromonas species: an opportunistic enteropathogen in patients with inflammatory bowel diseases? A single center cohort study.
    Inflamm Bowel Dis. 2015;21:71-8.
    PubMed     Text format     Abstract available


  530. JUILLERAT P, Sokol H, Froehlich F, Yajnik V, et al
    Factors associated with durable response to infliximab in Crohn's disease 5 years and beyond: a multicenter international cohort.
    Inflamm Bowel Dis. 2015;21:60-70.
    PubMed     Text format     Abstract available


  531. LONG MD, Cadigan RJ, Cook SF, Haldeman K, et al
    Perceptions of patients with inflammatory bowel diseases on biobanking.
    Inflamm Bowel Dis. 2015;21:132-8.
    PubMed     Text format     Abstract available


  532. YANG SK, Hong M, Choi H, Zhao W, et al
    Immunochip analysis identification of 6 additional susceptibility loci for Crohn's disease in Koreans.
    Inflamm Bowel Dis. 2015;21:1-7.
    PubMed     Text format     Abstract available


  533. SERWAS NK, Kansu A, Santos-Valente E, Kuloglu Z, et al
    Atypical manifestation of LRBA deficiency with predominant IBD-like phenotype.
    Inflamm Bowel Dis. 2015;21:40-7.
    PubMed     Text format     Abstract available


  534. SERIL DN, Yao Q, Lashner BA, Shen B, et al
    Autoimmune features are associated with chronic antibiotic-refractory pouchitis.
    Inflamm Bowel Dis. 2015;21:110-20.
    PubMed     Text format     Abstract available


  535. KIM KJ, Lee Y, Park SH, Kang BK, et al
    Diffusion-weighted MR enterography for evaluating Crohn's disease: how does it add diagnostically to conventional MR enterography?
    Inflamm Bowel Dis. 2015;21:101-9.
    PubMed     Text format     Abstract available


  536. PAPAMICHAEL K, Gils A, Rutgeerts P, Levesque BG, et al
    Role for therapeutic drug monitoring during induction therapy with TNF antagonists in IBD: evolution in the definition and management of primary nonresponse.
    Inflamm Bowel Dis. 2015;21:182-97.
    PubMed     Text format     Abstract available


  537. STODDARD PB, Ghazi LJ, Wong-You-Cheong J, Cross RK, et al
    Magnetic resonance enterography: state of the art.
    Inflamm Bowel Dis. 2015;21:229-39.
    PubMed     Text format     Abstract available


  538. LAN A, Blachier F, Benamouzig R, Beaumont M, et al
    Mucosal healing in inflammatory bowel diseases: is there a place for nutritional supplementation?
    Inflamm Bowel Dis. 2015;21:198-207.
    PubMed     Text format     Abstract available


    December 2014
  539. WILDT S, Rumessen JJ, Nordgaard-Lassen I
    Incorrect citation and analysis in meta-analysis.
    Inflamm Bowel Dis. 2014;20:E25.
    PubMed     Text format    


    September 2014
  540. GUSEVA D, Holst K, Kaune B, Meier M, et al
    Serotonin 5-HT7 receptor is critically involved in acute and chronic inflammation of the gastrointestinal tract.
    Inflamm Bowel Dis. 2014;20:1516-29.
    PubMed     Text format     Abstract available


  541. ASCOLANI M, Mescoli C, Palmieri G, Sica G, et al
    Colonic phenotype of the ileum in Crohn's disease: a prospective study before and after ileocolonic resection.
    Inflamm Bowel Dis. 2014;20:1555-61.
    PubMed     Text format     Abstract available


  542. MANSER CN, Frei P, Grandinetti T, Biedermann L, et al
    Risk factors for repetitive ileocolic resection in patients with Crohn's disease: results of an observational cohort study.
    Inflamm Bowel Dis. 2014;20:1548-54.
    PubMed     Text format     Abstract available


  543. SVRCEK M, Piton G, Cosnes J, Beaugerie L, et al
    Small bowel adenocarcinomas complicating Crohn's disease are associated with dysplasia: a pathological and molecular study.
    Inflamm Bowel Dis. 2014;20:1584-92.
    PubMed     Text format     Abstract available


  544. CARUSO A, D'Inca R, Scarpa M, Manfrin P, et al
    Diffusion-weighted magnetic resonance for assessing ileal Crohn's disease activity.
    Inflamm Bowel Dis. 2014;20:1575-83.
    PubMed     Text format     Abstract available


  545. PLEVINSKY JM, Greenley RN
    Exploring health-related quality of life and social functioning in adolescents with inflammatory bowel diseases after attending camp oasis and participating in a Facebook group.
    Inflamm Bowel Dis. 2014;20:1611-7.
    PubMed     Text format     Abstract available


  546. SHERMAN J, Greenstein AJ, Greenstein AJ
    Ileal j pouch complications and surgical solutions: a review.
    Inflamm Bowel Dis. 2014;20:1678-85.
    PubMed     Text format     Abstract available


  547. LI Y, Zhu W, Gong J, Zuo L, et al
    Influence of exclusive enteral nutrition therapy on visceral fat in patients with Crohn's disease.
    Inflamm Bowel Dis. 2014;20:1568-74.
    PubMed     Text format     Abstract available


  548. WRIGHT EK, De Cruz P, Gearry R, Day AS, et al
    Fecal biomarkers in the diagnosis and monitoring of Crohn's disease.
    Inflamm Bowel Dis. 2014;20:1668-77.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: